Quarterlytics / Financial Services / Asset Management / Sopheon Plc / FY2014 Annual Report

Sopheon Plc
Annual Report 2014

SPE · LSE Financial Services
Claim this profile
Ticker SPE
Exchange LSE
Sector Financial Services
Industry Asset Management
Employees 51-200
← All annual reports
FY2014 Annual Report · Sopheon Plc
Loading PDF…
ANNUAL REPORT 2014

Sopheon’s mission is to help our 
customers achieve exceptional 
long-term growth and 
profitability through 
sustainable innovation.

Summary Results and Trends 

Chairman's Statement 

Strategic Report 

Financial Report 

Directors and Advisors 

Report on Directors’ Remuneration 

Directors’ Report 

Statement of Directors’ Responsibilities 

5

6

7

11

14

15

18

21

Auditors’ Report 

Consolidated Income Statements 
and Consolidated Statements of
Comprehensive Income 

Consolidated and Company Balance Sheets 

Consolidated and Company  
Cash Flow Statements 

Consolidated and Company Statements 
of Changes in Equity 

Notes to the Financial Statements 

22

24

25

26

27

28

Sopheon’s mission is to help our customers 
achieve exceptional long-term growth and 
profitability through sustainable innovation.

We do this by providing software, services and best practices that help complex, global enterprises to 
increase the return on their R&D and broader innovation investments.  We provide transparency and insight 
to improve decision making through an integrated innovation platform which drives performance across 
four distinct business capabilities required to achieve sustainable 
innovation.

Conventional
Approach

Sopheon’s
Approach

Good execution of a bad strategy drives bad results.  The Sopheon 
solution was designed from the start to ensure that business 
strategy stays front of mind throughout the project life cycle, 
ensuring market success. 

Project Orientation

Strategy Orientation

Focus on Rolling
Up Projects

Focus on Achieving
Corporate Strategy

Short-Term

Long-Term

How do we optimize our
portfolio for achieving our
performance goals?

Strategy

Execution

Should this new idea/concept 
get funds/resources to move 
to the next stage?

olio O p ti

rtf
o
P

P

r

o

c

M

e

s

a

s

n

ti o n  

                    Innova

ti

Which strategies (segment brands,
product lines, platforms)
should we prioritize to achieve 
our growth objectives?

a

m iz

o

n

P

l

a

n

n

i

n

g

Enterprise
Innovation
Performance

&

a

g

e

m

e

 Project                    
nt                            

e a/Concept 
e v elopment 

         I d
             D

Should this new idea/concept
become a development
initiative/project?

VESUVIUS: black 85%VESUVIUS: whiteA selection of products and brands powered by Accolade. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
First to introduce smart 
technologies and PPT 
on a single click

First to embed 
graphical “product 
life cycle” stages

PPT
XLS
DOC
MPP

First to implement 
enterprise-wide, 
fully-integrated 
Innovation Planning 
and Roadmapping

First to embed 
30 years of 
best-practice 
know-how

First to introduce 
integrated roadmapping, 
planning, execution, 
ideation and portfolio 
in one solution

First to 
automate
Stage-Gate®

First and only to provide a 
genetic (learning) algorithm to 
assist with portfolio alignment 
(smart optimization)

250

200

150

100

50

0

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

Since inception Sopheon has built 
a roster of almost 230 licensees, 
including some of the world’s best 
known companies and brands. 
We added ten new customers in 
2014 – across a broad range of 
industries including defense, oil, 
and high-technology as well as 
in our traditionally core consumer 
goods and chemical sectors.

6 

CHAIRMAN'S STATEMENT

7

C H A I R M A N ' S   S TAT E M E N T

We entered 2014 on the back of the strongest quarter in our history, and having taken the 
business from under $13m revenues in 2009 to almost $21m in 2013.  This advance was 
coupled with steady improvements in profitability.  We also entered 2014 in the second 
year of a strategic transition from delivering process automation, to delivering enterprise 
class, integrated innovation management solutions.  We made substantial progress in 2014 
completing this shift in our business model but not without some disruption to momentum, 
leading to revenues of $18.3m in 2014.  The transition has taken longer than we had 
planned.  With much of the organizational change and restructuring now behind us, I wish 
to re-emphasize my belief in our growth strategy.  We continue to lead the market for innovation management 
solutions, with a breadth of vision, experience and capability that is unmatched by competitors that have 
emerged in recent years.  We believe that the restructuring we have undergone to better address the enterprise 
market is the right path for the Sopheon business, at a time when we also believe that this market is maturing.  

The closing quarter has always been busy and this was true for 2014.  As previously announced, a number of 
our larger opportunities were deferred into 2015.  One of our learnings last year was that enterprise solutions, 
while larger in value, require an even longer sales cycle than our historical business.  Delays often reflect the 
impact of a more intense decision-making process due to its strategic importance; this was not fully anticipated, 
but underlines the importance and value of our integrated innovation management solution.  In spite of this, 
revenue visibility coming into 2015 was $10.2m, only modestly down on $10.8m from the year before.  This 
reflects the strengthening recurring revenue base coupled with good levels of services backlog from deals that 
did close at the end of 2014. 

We added ten new customers in the year – across a broad range of industries including defense, oil, and high-
technology as well as in our traditionally core consumer goods and chemical sectors.  The investment and 
transformation in our sales organization has been completed, with new leadership in the US and Europe as well 
as several new team members, and dedicated resources bringing focus between new customer acquisition and 
existing customer account management.  Partners and resellers continued to bring us into new opportunities 
and were instrumental in acquiring new customer wins.  Our services organization was also restructured to 
support our growth strategy, and furthermore, we have brought services, support and development under 
common leadership.  

Ongoing investment in software development delivered a continued rapid pace of releases, with Accolade 9.1 
and 9.2 released in April and September respectively, and most recently Accolade 9.3 in February 2015.  We 
continue to bring forward new and unique functionality.  Areas of enhanced capability include roadmapping, 
resource planning and project execution, and deeper security and integration facilities – meeting the needs 
of new vertical segments as well as enterprise class requirements.  As announced in January, we are also 
introducing Accolade Express, which enables customers to leverage Sopheon software to rapidly improve 
innovation performance, by adopting out-of-the-box best practices content developed from over a decade of 
experience with industry leaders.

Early in the year, we were delighted to conclude $3.5m in new debt facilities with Silicon Valley Bank.  In 
December, we successfully completed the share consolidation and capital reduction process initiated the year 
before, with a cumulative reduction of very small shareholdings by approximately 10,000 across the UK and 
the Netherlands.  Sopheon’s board stood behind fractional entitlements that were sold on the market and 
purchased the equivalent of 471,500 current ordinary shares, underscoring our belief in the business. 

We remain confident in our strategic path.  We look forward to improved commercial progress this year, to 
match and leverage the major strides made with organizational, product and corporate matters. 

Barry Mence
Executive Chairman

18 March 2015

Sopheon and Accolade are registered trademarks of Sopheon plc.  
Accolade Roadmapping, Innovation Planner, Idea Lab, Process Manager, Portfolio Center and Vision Strategist are 
trademarks of Sopheon plc. 
Microsoft is a registered trademark of the Microsoft Corporation in the United States and/or in other countries.
Stage-Gate is a registered trademark of the Product Development Institute, Inc.

 
 
6 

STRATEGIC REPORT

7

S T R AT E G I C   R E P O R T

In this report, our CEO Andy Michuda provides more details on Sopheon’s mission and 
differentiation, our principal growth strategies, and an update on our people, processes and 
platform.  A summary of the principal risk areas facing the business is set out in the Directors’ 
Report.  Further analysis of Sopheon’s financial results during the year, including a review of 
the business, the financial position at the end of the year, key indicators and an overview of 
key corporate developments are set out in the Financial Report that follows and forms part of 
this Strategic Report.

What We Do

Sopheon’s mission is to help our customers achieve exceptional long-term growth and profitability through 
sustainable innovation.  We do this by providing software and services that help complex, global enterprises to 
increase the market success rate of their innovation efforts, to improve R&D throughput and time to market, and 
to increase the value per product or service in their innovation portfolio.  We provide transparency and insight 
to improve decision making through an enterprise innovation platform which drives performance across the four 
distinct business capabilities required to achieve sustainable innovation.

•  Strategic alignment of long-term Innovation Plans with market requirements, industry regulations, and 

supply chain capabilities; to create stronger strategic initiatives and priorities. 

•  Generation and development of higher value Ideas and Concepts to fill key gaps relevant to achieving 

strategic initiatives.

•  Improved Process and Project Management that tracks and enables key decision making, focused on 
evaluating projects associated with innovation initiatives, and accelerating productivity and velocity of 
development efforts through better execution and collaboration.

•  Data management, analytics and integrity tools improve project management and Portfolio Optimization to 

ensure the best return on innovation investments. 

How do we get more 
from our portfolio?

Accolade Portfolio Center
Resource Planning

Is our portfolio achieving 
our performance goals?

Should this initiative move 
forward for launch?

Accolade Process Manager
Collaborative Workflow

Should this initiative move 
into development?

olio O p ti

rtf
o
P

P

r

o

c

M

e

s

a

s

n

&

a

g

e

m

What plans do we create to 
achieve business objectives?

Accolade Innovation Planner
Accolade Roadmapping

Which strategies 
will we pursue?

a

m iz

ti o n  

                    Innova

ti

o

n

P

l

a

n

n

i

n

g

Enterprise
Innovation
Performance

e

 Project                    
nt                             

e a/Concept 
e v elopment 

         I d
             D

Which ideas/concepts support
our strategic objectives?

Accolade Idea Lab
Accolade Idea Submission

Which ideas/concepts 
are viable initiatives?

Research indicates that on average, only 50 percent of new products achieve their desired business 
objectives.  We have helped customers implement effective innovation management processes to dramatically 
increase this success rate, with some as high as 85 percent.

A common innovation and new product development challenge companies face is coordinating resources to bring 
products to market.  We help improve throughput efficiency, enabling 15-30 percent more products to be 
brought to market for the same investment.

Companies can increase the value of their portfolios by 75-100 percent or more, by connecting innovation 
planning to business objectives, developing better initiatives in the innovation funnel, more effectively managing 
processes, and optimizing portfolios with our Accolade solution.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9

8 

STRATEGIC REPORT

What Makes Sopheon Different

The Sopheon solution was designed from the start to ensure that business strategy stays front of mind, 
focusing on the business value that really matters to corporations.  During 2014 a specific focus was on 
developing tighter integration of long-range planning functionality with near-term execution capabilities –  
an increasingly vital requirement in an ever more competitive and unpredictable world.

Conventional
Approach

Sopheon’s
Approach

Project Orientation

Strategy Orientation

Focus on Rolling
Up Projects

Focus on Achieving
Corporate Strategy

Our integrated support for the entire lifecycle enables critical decision making at every 
step to help companies achieve significant innovation performance improvements 
across the enterprise.  Sopheon’s solutions have been implemented by over 200 
customers with over 60,000 users in over 50 countries.

Customer Value Trends

“Studies have found 
that two-thirds to 
three-quarters of large 
organizations struggle 
to implement their 
strategies.”

We see a convergence of several business, economic and market trends that 
play directly into Sopheon’s market position, solutions and investments.  We have 
identified three major trends from interactions with our customers, in the 
market, and from research sources.  We believe that Sopheon is uniquely 
positioned to leverage these trends with our proven solutions, services, 
expertise and best practices.

Why Strategy Execution Unravels—
and What to Do About It
Harvard Business Review, March 2015

•  Business Transformation – Companies are exploring innovative options to transform their business 
models for increased competitiveness, disruptive operating models, and greater connectedness with 
customers, and other strategic initiatives.  Sopheon provides these companies with solutions to undertake 
these high-risk/high-reward initiatives with structured planning, governance and performance measurement 
that greatly improve success probabilities.

•  Increased Operating Plan Cadence – Most companies are realizing that the traditional annual operating 
plan (AOP) done in spreadsheets and presentations is not effective and does not systematically drive 
relevant action, results and alignment in innovation initiatives.  Companies face increasingly disruptive and 
unplanned events in their markets which requires an ability to quickly assess the market situation, make 
fact-based informed decisions, and then implement appropriate actions.  Sopheon’s solutions integrate 
strategic initiatives with the day to day operating activities in a way that enables fast, dynamic adjustments 
based on continuous changes in market condition.

•  Sustainable Innovation – Moving with speed remains a struggle for large global companies due to rising 
complexity inherent in their business models.  Sopheon’s integrated innovation management platform 
allows our customers to cut through the complexity, improving the rate of innovation.  This means that a 
CEO-level objective can be driven, propagated, managed and tracked through all areas and levels of the 
enterprise.  The flexibility with which Sopheon’s solutions can be applied uniquely supports this enterprise 
process need.

 
8 

STRATEGIC REPORT

9

Growth Strategies

Sopheon’s growth strategy centers on transitioning our business from 
“automating New Product Development” to “delivering Enterprise 
Innovation Management solutions.”  This sharper strategic focus is 
informed by experiences from some of our early client successes, 
supplemented by recent validation from industry shifts and trends.  
It has required us to redirect our selling channels, service delivery 
model and roadmap priority towards a higher value proposition, 
interconnected with offering customers a more strategic solution.  
Our refined focus requires Sopheon to:

•  Increase industry-specific alignment of solutions and 

“Many CEOs feel they can’t 
move fast enough on the 
innovation front. But the most 
successful CEOs are doing 
three things to ‘industrialise’ 
innovation, i.e. to make it 
repeatable, dependable and 
scalable: they’re focusing on 
breakthrough innovation in all 
its forms; putting disciplined 
innovation techniques in 
place; and collaborating 
much more actively.”

marketing:  We have always believed that different vertical 
markets, while sharing core functionality needs, have differing  
pain-points and best-practice traditions.  In 2014 we continued 
our objective to dominate in our chosen core verticals of 
chemical, consumer products and high-tech.  The focus on 
enterprise innovation management is enabled by our ability 
to leverage the deep industry knowledge we have developed over the years, to bring more value to our 
clients across their enterprise.  Our progress and success as deploying this strategy in the consumer 
products market has been recognized by the fact that we have again – five years running – been voted 
among the top 10 providers of Innovation Solutions by consumer goods executives.  Our ambition is to 
replicate this success in the years to come with ongoing initiatives in the other core sectors, chemicals and 
high-tech.  

17th Annual Global CEO Survey
PwC, 2014

•  Introduce new offerings to leverage growth from our customer base:  Sopheon’s roster of customer 
names is a hugely impressive list of the world’s leading companies.  Our strategy calls for us to continue 
to expand the range of our innovation solutions, extending our footprint within our customers across 
their enterprise, to deliver considerably higher value for their investment in Accolade.  Examples of this 
product strategy in recent years include our 2012 release of Accolade Innovation Planner™ and the 
migration of Accolade Vision Strategist™ (now known as Accolade Roadmapping™) to our core Accolade 
platform, offering a single-database repository for strategic planning, operational execution and portfolio 
decision making.  We believe this is unique.  In 2014 we have invested in dedicated account management 
resources, and in social marketing programs focused on our customer base, to support our client growth 
strategy.

•  Transition distribution channels for Enterprise Solution selling:  We recognize that selling enterprise 
class, integrated solutions requires different skills to selling automation tools.  This strategy has led to 
several changes in our distribution model.  In the US we completed the migration to a hunter/farmer sales 

and marketing model with dual goals and targets for new customer acquisition, 
along with extension and retention of our existing customer base.  This 

“Projects are divided into 
different stages, each leading to 
a specific gate where decisions 
about the next stage are taken. 
Accolade is a software tool for 
managing this kind of processes. 
It will help Treofan bring more 
focused innovation to the market 
in less time. It will also help the 
company focus its innovation 
resources in the most efficient 
and effective way.”

process took longer than anticipated but we are pleased to have all roles 
transferred and filled coming into 2015.  These changes have been led 
by Sheila Plunkett, who was appointed in the first half of 2014 to lead 
the North American sales team.  In November we also appointed 
Pieter Leijten to lead our European sales team.  Sheila and Pieter 
have extensive experience with software companies such as IBM, 
SAP and Infor, as well as start-up environments, and they bring us 
deep experience in selling enterprise solutions.  We also continued 
to develop our ties with consulting firms, an area we believe will be 
key to the acceleration of our growth. 

Peter Vanacker
Chief Executive Officer, Treofan

 
 
1 1

1 0 

STRATEGIC REPORT

People, Process & Platform

People & Process

Sopheon is differentiated in the market by its industry-leading reputation for deep domain expertise in the 
product development business process referred to as “Stage-Gate®”.  Over recent years the market has pulled 
Sopheon more holistically into the broader innovation management space.  That know-how is instituted in our 
methodologies, our best practices and our substantial experience developed through many years of helping 
top businesses achieve innovation success.  We are very proud of the commitment that our people have 
shown to the company.  We place great emphasis on the development of our people to institutionalize this 
deep experience and knowledge of enterprise integrated innovation in our customer facing teams.  This priority 
continues to have high visibility inside our company.  

We have continued our transformation of the global Customer Success (consulting and implementation 
services) organization, embedding standardized methodologies and reporting mechanisms to support integrated 
innovation management.  Our services teams are customer-facing in their activities, relationships and service 
delivery and, increasingly, are vertically aligned to our target industries.  Similarly, the Customer Support 
organization is a single global team with people located across time zones to support local customer requests.  
Our Success and Support organizations now report to Don Sarno, who led the transformation of our product 
development approach to Agile and who has now taken on a Chief Operating Officer role.

Platform

Over the years Sopheon has made significant investments in product development as a commitment to 
maintaining our leadership of a market we helped to create through our own innovation.  These investments 
have been consistently held above 20 percent of revenue.  Our Product Development organization operates 
using an Agile methodology.  Our goal is to deliver three major releases a year.  Leveraging our industry-
standard .NET foundation, the Agile methodology drives greater customer interaction and feedback directly into 
the development process.  It allows maximum flexibility to respond to market needs, while at the same time 
supporting strategic needs.  

We continued a rapid pace in 2014 with Accolade 9.1 and 9.2 released in April and September respectively, 
and have most recently released Accolade 9.3 in February 2015.  Amongst a host of other improvements, 
these new versions stepped up our functionality in roadmapping, resource planning and project execution.  In 
addition, Accolade 9.1 introduced a range of security enhancements while Accolade 9.2 had greater focus 
on additional integration capabilities with the latest versions of Microsoft® Office.  Our releases continue to be 
aligned to market needs and reflect 
extensive input from our customer 
panels.  Alongside Accolade 9.3 
we have also released the first 
iteration of our new Accolade 
Express offering, which will enable 
enterprises to rapidly automate 
innovation processes based on 
implementing out-of-the-box best 
practices rooted in Sopheon’s 
extensive experiences with 
industry-leading customers.

Sopheon’s Accolade solution provides integrated support for the entire 
innovation and new product development lifecycle, including innovation planning, 
roadmapping, idea and concept development, process and project management, 
portfolio management, and resource planning.

Beyond the market and customer inputs, at the strategic level we continue to track four key product roadmap 
drivers – social, mobile, cloud and information.  These drivers mesh with global trends that are facing the 
majority of software companies today, and we are focused on ensuring that new releases keep pace with 
market expectations in these areas.

Approved by the board on 18 March 2015 and signed on its behalf by:

Andy Michuda 
CEO

Accolade® Solution• Innovation & NPD Process• Project & Portfolio    Management (PPM)• Collaborative Workflow• Stage-Gate® & Other    Process Automation• Time TrackingInnovationPlannerRoadmappingIdea LabProcess ManagerPortfolio Center• Define Targets & Strategies• Multi-Layer Planning• Planning Board• Taxonomy Visualization• Real-Time Collaboration• Market, Product & Technology Planning• Roadmapping Automation• Dependencies• Milestones• Conflict Resolution• Gantt & Composite Views• Idea & Concept Development • Campaigns• Communities• Collaboration• Ideation Accelerator• Reputation• Portfolio Optimizer• Portfolio Classes• Portfolio Accelerator• Scenarios• Resource Planning• Ranking & Prioritization 
1 0 

FINANCIAL REPORT

1 1

F I N A N C I A L   R E P O R T

In this report, our CFO Arif Karimjee provides further analysis of Sopheon’s financial results 
during 2014, our financial position at the end of the year, and an overview of key corporate 
developments.  In view of the fact that two-thirds of Sopheon’s revenues and staff are 
based in the USA, the board took the decision to present the group’s financial statements 
in US Dollars as of the 2014 interim report.  This is the first annual report reflecting this 
change.  It is intended to reduce the effect of currency movements on reported revenues, 
and to better reflect the underlying source of the majority of the group’s business. 
Comparatives for the prior period have been restated accordingly. 

Trading Performance

Sopheon’s consolidated turnover in 2014 was $18.3m, compared to $20.8m in 2013.  The overall shape of 
the business continues to be approximately one-third Europe and two-thirds North America, with a material 
contribution from other territories including Asia, the Pacific Rim and the Middle East.  

Total license transactions including extension orders were 42 in 2014, compared to 47 in 2013.  A trend in the 
previous two years of rising average revenue per transaction was interrupted, which in conjunction with the 
lower transaction count resulted in a lower overall sales performance.  Accordingly, while maintenance and 
hosting revenues remained broadly consistent with the prior year, license and services revenues both fell back.  
Taking the long view, the annualized average growth of our business since the launch of Accolade remains 
above 20 percent.  

Business Mix

Over the years we have frequently referred to the sensitivity of our license results to individual sales events.  
Historically, the second and fourth quarters tend to be strong and the final quarter of 2013 was a particularly 
marked example, being the strongest revenue quarter in our history.  In 2014, while the second and fourth 
quarters were certainly stronger than the first and third, they did not match the prior year performance.  In 
particular, and as we announced towards the end of 2014, a number of large transactions that we had 
originally expected to close in the fourth quarter were delayed into 2015.  Such delays are often reflective of 
an opportunity growing in size and scale; potentially a good long-term outcome but of course the impact on the 
year under review can be unwelcome.  This deferral of larger orders also contributed to the average deal size 
being lower than in the prior year, as referenced above. 

Although overall sales were lower, the contribution from new customers improved to 45 percent from 35 percent 
in 2013, reflecting a number of exciting new customer wins.  We entered last year determined to improve 
new sales performance, and backed this up with a recruitment strategy in North America that was focused on 
ensuring better segregation between hunter and farmer sales representatives.  In addition to the appointment of 
a new sales leader in April, by the end of 2014 we had ten sales representatives in the US, of which five joined 
the team during the year.  In November we also brought on a new sales leader in Europe, where we ended the 
year with three experienced representatives and have just added a fourth. 

Attrition in the recurring revenue base was more than outweighed by the value of new contracts which means 
that the overall base of recurring business stood at approximately $7.9m coming into 2015, compared to $7.5m 
coming into 2014 and $7.1m coming into 2013.  We recognize that this rising trend of recurring revenue is 
key to our progress and stability, and have introduced programs alongside our focus on account management 
to ensure that it is nurtured.  The majority of recurring income is represented by maintenance services, but 
also includes hosting and cloud services.  Overall, in 2014 our business delivered a 21:42:37 ratio of licenses, 
maintenance, and services respectively compared to 29:35:36 in the previous year. 

Overall our reported gross margins were 66 percent, down from 70 percent in 2013, reflecting the lower level of 
high-margin license revenue, coupled with the relatively fixed costs in our services business.  

 
1 2 

FINANCIAL REPORT

1 3

Research and Development Expenditure

Overall investment in product development decreased by approximately $0.1m in 2014, following a steady 
annual rise since 2010; this compares to the headline R&D reported in the income statement showing a 
reduction from $4.8m to $4.3m.  The majority of the difference is due to the effects of capitalization and 
amortization of development costs.  The amount of 2014 research and development expenditure that met the 
criteria of IAS38 for capitalization was $2.4m (2012: $1.8m) offset by amortization charges of $2.1m (2013: 
$1.8m).  These capitalized costs are largely attributable to the group’s investment in the Accolade 9.1, 9.2 and 
9.3 releases.  In 2013, a further $0.1m of amortization and impairment charges relating to acquired intangible 
assets were charged to distribution costs; these were fully written down coming into 2014 and accordingly the 
charge did not recur.  

Sopheon remains committed to product leadership, with excellence in research and software development as a 
critical core competency of the group.  Since 2001 Sopheon’s reported research and development costs each 
year have been at least 20 percent of revenues reported in that year.  For 2014, this metric was 23 percent 
(2013: 23 percent).

Operating Costs

Coming into 2012 Sopheon had 95 staff members, which we grew to 116 by the end of 2013.  Following 
expansion of resources in line with revenue growth through 2012 and 2013, we stabilized headcount in light 
of developments last year and ended 2014 with 113 staff.  Although staffing numbers were broadly constant 
year on year, all cost areas were moderated by the reduced bonus attributable to the lower 2014 performance.  
The corporate bonus scheme covers the majority of the group’s executives and employees, with the principal 
exception of the sales teams for whom incentives are tied to individual or territory results.  Bonus costs in a 
given year are allocated to the relevant categories of the income statement.  

Detailed comments regarding professional services and research and development costs are noted above.  
After allowing for $0.1m lower amortization and impairment charge noted above, as well as lower commission 
costs, sales and marketing costs were broadly stable at $6.2m in 2014 compared to $6.3m in 2013.  

Headline administration costs have risen by $0.2m, mainly due to a swing from a net exchange gain position 
on the group’s cash balances to a net exchange loss.  As a matter of policy, the group does not hedge currency 
balances.  Underlying administration costs and resourcing have remained broadly constant since 2007.   

Results

In common with other technology businesses, the board believes EBITDA provides a useful indicator of the 
underlying performance of our business by removing the effect on earnings of tax, capital spend and financing.  
EBITDA is further defined and reconciled to profit before tax in Note 4. 

The combined effect of the revenue and cost performance discussed above has resulted in Sopheon’s EBITDA 
(Earnings before Interest, Tax, Depreciation and Amortization) performance for 2014 falling to $1.2m, from $3m 
in 2013.

Including the effect of interest, depreciation and amortization, the group reported a loss before tax for the year 
of $1.5m (2013: profit of $0.5m).  No tax has been provided.  The loss per ordinary share was 20.9 cents 
(2013: profit per share of 7.3 cents). 

 
1 2 

FINANCIAL REPORT

1 3

Balance Sheet and Corporate

Consolidated net assets at the end of the year stood at $4.2m (2013: $5.8m).  Gross cash resources at 31 
December 2014 amounted to $4.7m (2013: $4.0m).  Approximately $2.4m was held in US Dollars, $2.0m in 
Euros and $0.3m in Sterling.  

Intangible assets stood at $5.9m (2013: $5.6m) at the end of the year.  This includes (i) $4.9m being the net 
book value of capitalized research and development (2013: $4.6m) and (ii) an additional $1.0m (2013: $1.0m) 
being goodwill arising on the acquisitions of Alignent Software Inc., and Sopheon GmbH. 

Facilities

Since 2007 the company had term-loan and line of credit facilities provided by BlueCrest Capital Finance 
(“BlueCrest”).  BlueCrest decided to move away from debt funding and accordingly, further renewals were not 
available.  Accordingly, in February 2014 the group established new replacement facilities with the London 
branch of Silicon Valley Bank.  These facilities comprise a term loan of $0.5m repayable in 36 equal monthly 
instalments, and, reflecting the group’s expanded receivables capacity, a $3m revolving line of credit.  Both 
facilities bear interest at rates of 2.75 percent over Wall Street Prime, resulting in a current effective rate of 
6 percent.  The facilities are subject to covenants based on operating results, and in addition the drawdown 
mechanics and interest rates are subject to certain working capital ratios.  These facilities have substantially 
lower financing costs than the ones they replace, reflecting the growing maturity of the Sopheon business. 

To underpin the group’s growth strategies, in two tranches in 2009 and 2011, the company issued a total of 
£2m of convertible unsecured loan stock (the “Loan Stock”) to a group of investors including key members of 
the board and senior management team.  In June 2014, the Loan Stock investors agreed to extend the maturity 
date by two years to 31 January 2017.  The conversion price is 76.5 pence per share.  

As a final component of its financing structure, Sopheon has an equity line of credit facility with GEM Global 
Yield Fund Limited ("GEM") which was last renewed for a two-year term expiring on 23 December 2015.  The 
facility, which has been renewed on a number of previous occasions, has been used to raise working capital 
once, in March 2004.  This leaves approximately 90 percent of the original €10m facility available under the 
extended agreement.  Drawings under the GEM equity line of credit are subject to conditions relating inter alia 
to trading volumes in Sopheon shares.

Approved by the board on 18 March 2015 and signed on its behalf by: 

Arif Karimjee 
CFO

 
1 4 

DIRECTORS AND ADVISORS

1 5

D I R E C T O R S   A N D   A D V I S O R S

Directors 

Barry K. Mence 
Andrew L. Michuda 
Arif Karimjee ACA 
Stuart A. Silcock FCA 
Bernard P. F. Al 
Daniel Metzger 

Executive Chairman 
Chief Executive Officer 
Chief Financial Officer
Non-executive Director 
Non-executive Director
Non-executive Director

Secretary 

Arif Karimjee

Registered Office 

Registered Name and Number 

Dorna House One
Guildford Road
West End, Surrey GU24 9PW

Sopheon plc.
Registered in England and Wales  
No. 3217859

Lloyds TSB Bank plc.
77 High Street
Southend-on-Sea
Essex SS1 1HT

Briggs and Morgan
2200 IDS Center, 80 South Eighth Street
Minneapolis, MN 55402
United States

Auditors 

Principal Bankers and Financiers 

Solicitors and Attorneys 

AIM Nominated Adviser and Broker 

Alternext Paying Agent 

Registrars 

BDO LLP
55 Baker Street 
London W1U 7EU

Silicon Valley Bank 
3003 Tasman Drive 
Santa Clara, CA 95054 
United States 

Rabobank Amsterdam
Van Baerlestraat 102-106
1071 BC Amsterdam
The Netherlands

Squire Patton Boggs 
7 Devonshire Square 
Cutlers Gardens 
London EC2M 4YH 

Loyens & Loeff
Fred Roeskestraat 100
1076 ED Amsterdam
The Netherlands

finnCap Limited 
60 New Broad Street
London EC2M 1JJ

Kempen & Co.
Beethovenstraat 300
1077 WZ Amsterdam
The Netherlands

Capita Registrars
Northern House
Woodsome Park
Fenay Bridge
Huddersfield HD8 0LA

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 4 

REPORT ON DIRECTORS’ REMUNERATION

1 5

R E P O R T   O N   D I R E C T O R S ’   R E M U N E R AT I O N

The remuneration committee of Sopheon plc is responsible for oversight of the contract terms, remuneration and other 
benefits for executive directors, including performance-related bonus schemes.  The committee comprises two non-
executive directors, B.P.F. Al, as chairman, and S.A. Silcock, together with B.K. Mence, other than in respect of his 
own remuneration.  The committee makes recommendations to the board, within agreed parameters, on an overall 
remuneration package for executive directors and other senior executives in order to attract, retain and motivate high 
quality individuals capable of achieving the group’s objectives.  The package for each director consists of a basic salary, 
benefits and pension contributions, together with performance-related bonuses and share options on a case-by-case 
basis.  Consideration is given to pay and employment policies elsewhere in the group, especially when considering 
annual salary increases.  From time to time, the remuneration committee may take advice from appropriate remuneration 
consultants or to consult benchmarking data.

Contracts

The service contract between the company and Mr. Michuda is terminable on up to three months’ notice, with an 
additional twelve months’ salary in lieu of notice due by the company in the event of termination without cause.  Service 
contracts between the company and the other executive directors are terminable on six to nine months’ notice.

Fees for Non-executive Directors

The fees for non-executive directors are determined by the board.  The non-executive directors are not involved in any 
discussions or decisions about their own remuneration.

Directors’ Remuneration

Set out below is a summary of the fees and emoluments received by all directors during the year, translated where 
applicable into US Dollars at the average rate for the period.  Mr. Mence’s remuneration is largely fee-based and 
therefore subject to fluctuations from period to period.  Benefits primarily comprise healthcare insurance and similar 
expenses.  Details of directors’ interests in shares and options are set out in the Directors’ Report.

Executive Directors

B.K. Mence   
A.L. Michuda    
A. Karimjee    

Non-executive Directors

S.A. Silcock 
B.P.F. Al 
D. Metzger  

 Pay and Fees 
2014 
$ 

Bonus 
2014 
$ 

Benefits 
2014 
$ 

Total 
2014 
$ 

Total
2013
$

235,064  
283,750  
196,459  

-  
-  
-  

5,652  
12,596  
3,713  

240,716  
296,346  
200,172  

247,335 
312,503 
202,062

32,942 
32,942 
32,942 
_______ 
814,099 
_______ 
_______ 

- 
- 
- 
_______ 
- 
_______ 
_______ 

- 
- 
- 
_______ 
21,961 
_______ 
_______ 

32,942 
32,942 
32,942 
_______ 
836,060 
_______ 
_______ 

31,398 
31,398 
31,398
_______
856,094 
_______
_______

The remuneration committee establishes the objectives that must be met for each financial year if a cash bonus is to be 
paid.  With the principal exception of members of Sopheon’s sales teams, for whom incentives are tied to individual or 
territory results, the committee concluded that the cash incentive should be tied to the financial performance of the group 
as a whole, and in 2013 and 2014 these objectives were set with regard to EBITDA performance.  These measures were 
applied to all members of the executive board and management committee of the group, as well as the majority of the 
group’s employees. 

In addition to the amounts disclosed above, pension contributions are made to individual directors’ personal pension 
schemes.  During 2014 contributions of $8,030, $3,943 and $9,033 (2013: $7,653, $4,754 and $9,405) were paid 
respectively to the pension schemes of B.K. Mence, A.L. Michuda and A. Karimjee.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 6 

REPORT ON DIRECTORS’ REMUNERATION

1 7

Performance Graph

The following graph shows the company’s share price performance on AIM since January 2011, in UK pence, compared 
with the performance of the FTSE AIM All Share index, which has been selected for this comparison as it is a broad-
based index which the directors believe most closely reflects the performance of companies with similar characteristics 
as the group’s.  Historical share prices have been adjusted to reflect the net 20:1 share consolidation performed by the 
group during 2013. 

250

200

150

100

50

0

1
1

n
a
J

1
1
r
p
A

1
1

l

u
J

1
1
t
c
O

2
1

n
a
J

2
1
r
p
A

2
1

l

u
J

2
1
t
c
O

3
1

n
a
J

3
1
r
p
A

3
1

l

u
J

3
1
t
c
O

4
1

n
a
J

4
1
r
p
A

4
1

l

u
J

4
1
t
c
O

5
1

n
a
J

Sopheon

Aim All-Share (rebased to Sopheon)

Directors’ Interests

The interests of the directors, who held office at the end of the year, in the share capital of the company (all beneficially 
held except those marked with an asterisk (*), which are held as trustee), were as follows:

Share Options   

       Ordinary Shares 

      8%
Convertible
Loan Stock

At 31 December 

2014 

2013 

2014 

2013 

2014 

2013

B.K. Mence  
A.L. Michuda   
A. Karimjee  
S.A. Silcock  
S.A. Silcock*  
B.P.F. Al  
D. Metzger  

24,250 
199,880 
57,500 
- 
-  
1,125 
-  

24,250 
199,880 
57,500 
- 
-  
1,125 
-  

1,033,000 
30,000 
17,500 
145,000 
4,000 
61,500 
5,000  

722,500 
8,000 
4,500 
47,500 
4,000 
32,500 
5,000  

£640,000  £640,000
£45,000  £45,000
£27,000  £27,000
£200,000  £200,000
-
- 
£60,000  £60,000
-
-  

Of the 1,033,000 ordinary shares mentioned above B.K. Mence beneficially owns and is the registered holder of 917,000 
ordinary shares. His wife, Mrs. M.T. Mence, beneficially owns 500 ordinary shares.  A further 115,500 ordinary shares are 
held by Inkberrow Limited, a company which is owned by B.K. Mence.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 6 

REPORT ON DIRECTORS’ REMUNERATION

1 7

The following table provides information for each of the directors who held office during the year and held options to 
subscribe for Sopheon ordinary shares.  All options were granted without monetary consideration.

Date of 
Grant 

Exercise 
Price 

At 31 
December 
2013 

Granted 
During 
Year 

Expired 
During 
Year 

At 31
December
2014

B.K. Mence  
B.K. Mence   
A.L. Michuda   
A.L. Michuda  
A.L. Michuda  
A. Karimjee   
A. Karimjee  
A. Karimjee   
B.P.F. Al   

29 September 2012  
5 December 2013  
27 August 2010  
29 September 2012  
5 December 2013  

27 August 2010         

29 September 2012  
5 December 2013   
29 September 2012  

105p  
85p  

6,125  
18,125  
12,500         

150p         
105p  
85p  

138,380  
49,000  
150p                7,500   
23,125  
105p  
26,875  
85p  
1,250  
105p  

-  
-  
 -   
-  
-  
-  
-  
-  
-  

6,125
-  
18,125
-  
-          12,500
138,380
-  
49,000
-  
7,500
-  
23,125
-  
26,875
-  
1,250
-  

None of the directors exercised any share options during the year.  Vesting of all of the above share options which were 
outstanding at 31 December 2014 is in three equal tranches on the first, second and third anniversaries of the date of 
grant and all such options expire on the tenth anniversary of the date of grant.  The mid-market price of Sopheon ordinary 
shares at 31 December 2014 was 39.5p.  During the financial year the mid-market price of Sopheon ordinary shares 
(adjusted, where applicable, for the share consolidation and subsequent share subdivision referred to in Note 23) ranged 
from 39.5p to 96.5p. Save as disclosed above, no director (or member of his family) or connected persons has any 
interest, beneficial or non-beneficial, in the share capital of the company.

Approved by the board on 18 March 2015 and signed on its behalf by:

Arif Karimjee
Director

 
 
 
 
 
 
 
1 8 

DIRECTORS’ REPORT

1 9

D I R E C T O R S ’   R E P O R T

The group’s principal activities during the year continued to focus on the provision of software and services that improve 
the return on investment of product development, within the rapidly emerging product lifecycle management (PLM) market.  
A review of the development of the business during the year is given in the Chairman's Statement on page 6 and the 
subsequent Strategic and Financial Reports.  These also include reference to the group’s future prospects.  In view of the 
fact that two-thirds of the group’s revenues and staff are based in the USA, the directors have decided to present the group’s 
financial statements in US Dollars. The group’s result for the year ended 31 December 2014 is a loss after tax of $1,519,000 
(2013: profit $534,000).  As for the prior year, the directors do not intend to declare a dividend.

Corporate Governance

The Sopheon board is committed to high standards of corporate governance and aims to follow appropriate governance 
practice, although as a company incorporated in the UK and listed on AIM and Alternext the company is not subject to 
the requirements of the UK Corporate Governance Code or the Netherlands Tabaksblat Committee.  The board currently 
comprises three executive directors and three independent non-executive directors.  Their biographies appear at the back of 
this annual report, and demonstrate a range of experience and caliber to bring the right level of independent judgment to the 
board.

The board is responsible for the group’s system of internal control and for reviewing its effectiveness.  Such a system can 
only provide reasonable, but not absolute, assurance against material misstatement or loss.  The board believes that the 
group has internal control systems in place appropriate to the size and nature of its business.  The board is satisfied that the 
scale of the group’s activities do not warrant the establishment of an internal audit function.  The board is also responsible for 
identifying the major business risks faced by the group and for determining the appropriate course of action to manage those 
risks.  Formal meetings are held quarterly to review strategy, management and performance of the group, with additional 
meetings between those dates convened as necessary.  During 2014, all directors attended all quarterly meetings either in 
person or by conference call.  The audit committee, which comprises all of the non-executive directors and is chaired by 
Stuart Silcock, considers and determines actions in respect of any control or financial reporting issues they have identified or 
that are raised by the auditors.  The board has a formal schedule of matters specifically reserved to it for decision.  Details of 
the constitution of the remuneration committee are provided in the Report on Directors’ Remuneration on page 15.

Share Consolidation and Subsequent Subdivision of Shares

In May 2013 a reorganization of the company’s share capital was carried out, including a share consolidation and 
subsequent share subdivision intended to reduce the disproportionately large number of shareholders with relatively small 
shareholdings for a company of Sopheon’s size.  However, the capital reorganization was not correctly processed by certain 
brokers in the Netherlands.  Enquiries and representations established that this could not be rectified other than by repeating 
the process.  Accordingly, on 10 October 2014 shareholders approved a further share consolidation, on the basis of one 
new ordinary share of £100 nominal value for every 500 ordinary shares of 20p each.  On 18 December 2014 shareholders 
approved a further share subdivision, whereby each ordinary share of £100 nominal value was subdivided into 500 ordinary 
shares of 20 pence each.

Share Option Schemes

Details of options granted are shown in Note 27 to the financial statements.  

Post Balance Sheet Events

There are no post balance sheet events that warrant disclosure in the financial statements.  

 
1 8 

DIRECTORS’ REPORT

1 9

Principal Risk Areas

As with any business at its stage of development, Sopheon faces a number of risks and uncertainties.  The board 
monitors these risks on a regular basis.  The key areas of risk identified by the board are summarized below.

Sopheon’s markets are emerging and this means that Sopheon's growth may be erratic.  The broad market for 
Sopheon’s software products continues to emerge and evolve, and the timing and size of individual sales can have a 
substantial impact on performance in a given period.  Sopheon has formalized processes for soliciting input to product 
strategy from analysts and customers, while also capitalizing on the group’s leadership in key market areas.  Sopheon 
also seeks to improve revenue predictability by introducing specific initiatives to balance efforts between new customer 
acquisition, and meeting the needs of existing customers.

Sopheon’s prospects of achieving sustained and growing profitability are dependent on correctly aligning investments 
with sales.  Sopheon’s ability to continue to finance its investments at the optimal pace is dependent on the group 
maintaining profitability and sales growth alongside its investment strategy, or having appropriate financial resources 
in place to invest with confidence.  Sopheon has sought to focus its resources on the sub-segments that it believes 
offer the best opportunities for growth.  Sopheon management carefully monitors short- and medium-term financing 
requirements and has regularly raised additional funding resources to meet requirements.  

Some of Sopheon’s competitors and potential competitors have greater resources than Sopheon.  Sopheon remains a 
relatively small organization by global standards.  Its resources are small compared to those of many larger companies 
that are capable of developing competitive solutions and it can be difficult to overcome the marketing engine of a 
large global firm.  Sopheon seeks to compete effectively with such companies by keeping its market communications 
focused, clear and consistent with its product and market strategy, and working to deliver first class quality of execution 
so that referenceability of the customer base is maximized.  Sopheon’s use of an agile development methodology with 
deep customer involvement is a key plank in this approach.

Sopheon is dependent upon skilled personnel, the loss of whom could have a material impact.  While service 
agreements have been entered into with key executives, retention of key members of staff cannot be guaranteed and 
departure of such employees could be damaging in the short term.  In addition the competition for qualified employees 
continues to be difficult and retaining key employees has remained challenging.  As a relatively small business, 
Sopheon is more exposed to this risk than some of its larger competitors.  Sopheon management checks staff 
remuneration against recognized benchmarks and other industry sources, and seeks to maintain pay at competitive 
levels appropriate to its business.

Sopheon will require relationships with partners who are able to market and implement its products.  Historically, 
Sopheon has devoted substantial resources to the direct marketing of its products, and its strategy to enter into 
strategic alliances and other collaborative relationships to widen the customer base and create a broad sales and 
implementation channel for its products is not yet mature.  The successful implementation of this strategy is crucial to 
Sopheon’s prospects and its ability to scale effectively.  However, Sopheon cannot be sure that it will select the right 
partners, or that the partners it does select will devote adequate resources to promoting, selling and becoming familiar 
with Sopheon's products.  Over the years Sopheon has built up a network of both resellers and consulting partners, 
however this has yet to mature and the revenues delivered through these relationships remain a relatively modest part 
of the total.

Sopheon could be subject to claims for damages for errors in its products and services.  Sopheon may be exposed to 
claims for damages from customers in the event that there are errors in its software products or should support and 
maintenance service level agreements fail to meet agreed criteria.  Sopheon has sought to protect itself from such risks 
through excellent development methodologies, its contract terms and insurance policies.  Sopheon has never had any 
such claims.

Auditors

All of the current directors have taken all the steps that they ought to have taken to make themselves aware of any 
information needed by the company’s auditors for the purposes of their audit and to ensure that the auditors are aware 
of that information.  The directors are not aware of any relevant audit information of which the auditors are unaware.  A 
resolution to reappoint BDO LLP as auditors will be put to the members at the Annual General Meeting.

 
2 0 

DIRECTORS' REPORT 

Financial Instruments

Details of the group’s financial instruments and its policies with regard to financial risk management are given in  
Note 22 to the financial statements.

Substantial Shareholdings

The directors are aware of the following persons who as at 18 March 2015 were interested directly or indirectly in  
3 percent or more of the company’s issued ordinary shares:

Name
B.K. Mence (director) 
Rivomore Limited and Myrtledare Corp. 

No. of 

% Issued

Ordinary Shares  Ordinary Shares

1,033,000 
1,408,500 

14.2
19.4

B.K. Mence also holds £640,000 nominal of 8% convertible loan stock.  Rivomore Limited and Myrtledare Corp. also 
hold £640,000 nominal of 8% convertible loan stock.  The convertible loan stock is convertible at the rate of 76.5p per 
ordinary share.

B.K. Mence’s interest represents direct beneficial holdings as well as those of his family.

Approved by the board on 18 March 2015 and signed on its behalf by:

A. Karimjee 
Director

2 1

 
 
 
2 0 

STATEMENT OF DIRECTORS’ RESPONSIBILITIES 

2 1

S TAT E M E N T   O F   D I R E C T O R S ’   R E S P O N S I B I L I T I E S   I N 

R E S P E C T   O F   T H E   F I N A N C I A L   S TAT E M E N T S

The directors are responsible for preparing the annual report and financial statements in accordance with applicable law 
and regulations. 

Company law requires the directors to prepare financial statements for each financial year.  Under that law the directors 
have elected to prepare the group and company financial statements in accordance with International Financial 
Reporting Standards (IFRSs) as adopted by the European Union.  Under company law the directors must not approve 
the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group 
and company and of the profit or loss of the group for that period.  The directors are also required to prepare financial 
statements in accordance with the rules of the London Stock Exchange for companies trading securities on the 
Alternative Investment Market and the rules of the NYSE Alternext Amsterdam Stock Exchange. 

In preparing these financial statements, the directors are required to:

•  select suitable accounting policies and then apply them consistently;

•  make judgments and accounting estimates that are reasonable and prudent;

•  state whether they have been prepared in accordance with IFRSs as adopted by the European Union, subject to 

any material departures disclosed and explained in the financial statements; and

•  prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company 

will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the 
company’s transactions and disclose with reasonable accuracy at any time the financial position of the company 
and enable them to ensure that the financial statements comply with the requirements of the Companies Act 2006.  
They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the 
prevention and detection of fraud and other irregularities.

Website Publication

The directors are responsible for ensuring the annual report is made available on a website.  Annual reports are 
published on the company's website in accordance with legislation in the United Kingdom governing the preparation 
and dissemination of financial statements, which may vary from legislation in other jurisdictions.  The maintenance and 
integrity of the company's website is the responsibility of the directors.  The directors' responsibility also extends to the 
ongoing integrity of the annual reports contained therein.

 
2 2 

INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF SOPHEON PLC

2 3

I N D E P E N D E N T   A U D I T O R S ’   R E P O R T   T O   T H E   M E M B E R S   O F 

S O P H E O N   P L C

We have audited the financial statements of Sopheon plc for the year ended 31 December 2014 which comprise the 
consolidated income statement, the consolidated statement of comprehensive income, the consolidated and company 
balance sheets, the consolidated and company cash flow statements, the consolidated and company statements of 
changes in equity, and the related notes.  The financial reporting framework that has been applied in their preparation 
is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union and, as 
regards the parent company financial statements, as applied in accordance with the provisions of the Companies Act 
2006. 

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the 
Companies Act 2006.  Our audit work has been undertaken so that we might state to the company’s members those 
matters we are required to state to them in an auditor’s report and for no other purpose.  To the fullest extent permitted 
by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a 
body, for our audit work, for this report, or for the opinions we have formed.

Respective Responsibilities of Directors and Auditors

As explained more fully in the statement of directors’ responsibilities, the directors are responsible for the preparation 
of the financial statements and for being satisfied that they give a true and fair view.  Our responsibility is to audit 
the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland).  
Those standards require us to comply with the Auditing Practices Board’s (APB’s) Ethical Standards for Auditors.

Scope of the Audit of the Financial Statements

A description of the scope of an audit of financial statements is provided on the APB’s website at 
www.frc.org.uk/apb/scope/private.cfm

Opinion on Financial Statements

In our opinion:

•  the financial statements give a true and fair view of the state of the group’s and the parent company’s affairs as at 

31 December 2014 and of the group’s loss for the year then ended;

•  the group financial statements have been properly prepared in accordance with IFRSs as adopted by the 

European Union;

•  the parent company financial statements have been properly prepared in accordance with IFRSs as adopted by 

the European Union; and

•  the financial statements have been prepared in accordance with the requirements of the Companies Act 2006.

Opinion on Other Matters Prescribed by the Companies Act 2006

In our opinion the information given in the Strategic Report and the Directors’ Report for the financial year for which the 
financial statements are prepared is consistent with the financial statements.

 
 
2 2 

INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF SOPHEON PLC

2 3

Matters on Which We are Required to Report by Exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to 
you if, in our opinion:

•  adequate accounting records have not been kept by the parent company, or returns adequate for our audit have 

not been received from branches not visited by us; or

•  the parent company financial statements are not in agreement with the accounting records and returns; or

•  certain disclosures of directors’ remuneration specified by law are not made; or

•  we have not received all the information and explanations we require for our audit.

Julian Frost (senior statutory auditor)
For and on behalf of BDO LLP, statutory auditor
55 Baker Street
London W1U 7EU
United Kingdom

18 March 2015

BDO LLP is a limited liability partnership registered in England and Wales (with registered number OC305127).

 
2 4 

FINANCIAL STATEMENTS

2 5

C O N S O L I D AT E D   I N C O M E   S TAT E M E N T

F O R   T H E   Y E A R   E N D E D   3 1   D E C E M B E R   2 0 1 4

Revenue 
Cost of sales      

Gross profit 

Sales and marketing expense      
Research and development expense       
Administrative expense      

Operating (loss)/profit 

Finance income 
Finance expense 

(Loss)/profit before tax       

Income tax expense 

(Loss)/profit for the year   

(Loss)/earnings per share
Basic and fully diluted (US cents) 

Notes 

2014 
$’000 

2013
$’000

3 

18,296 
(6,209) 
_______ 

20,841 
(6,296) 

_______

12,087 

14,545

(6,173) 
(4,298) 
(2,718) 
_______ 

(6,331)
(4,776)
(2,486)  

_______ 

(1,102) 

952 

8 
9 

12 
(429) 
_______ 

27
(445)
_______

(1,519)  

534

     10 

- 
_______ 

-
_______

5    

(1,519)  

_______ 

534
_______

12 

(20.87c) 
_______ 
_______ 

7.34c
_______
_______

C O N S O L I D AT E D   S TAT E M E N T   O F   C O M P R E H E N S I V E   I N C O M E 

F O R   T H E   Y E A R   E N D E D   3 1   D E C E M B E R   2 0 1 4

(Loss)/profit for the year 

Other comprehensive expense
Exchange differences on translation of foreign operations 

Total comprehensive (expense)/income for the year 

2014 
$’000 

2013
$’000

(1,519) 

534 

(197) 
_______ 

(99) 
_______  

(1,716) 

_______ 
_______ 

435
_______
_______

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 4 

FINANCIAL STATEMENTS

2 5

C O N S O L I D AT E D   A N D   C O M PA N Y   B A L A N C E   S H E E T S   AT   

3 1   D E C E M B E R   2 0 1 4

Notes 

2014 
$’000 

Company 

2012 
$’000 

2014 
$’000 

2013 
$’000 

2012
$’000

Assets

Non-current Assets

Property, plant and equipment        13  
14  
Intangible assets   
15  
Investments in subsidiaries   
16  
Other receivable   

Total non-current assets 

Current Assets

Trade and other receivables 
Cash and cash equivalents   

17 
18  

Total current assets 

Total assets 

Liabilities

Current Liabilities

Trade and other payables 
Borrowings   
Deferred revenue    

Total current liabilities 

Non-current Liabilities

19 
20  

Borrowings 

20 

Total non-current liabilities 

Total liabilities 

Net assets 

Equity

Share capital 
Capital reserves   
Translation reserve    
Retained losses    

Total equity 

Group 

2013 
$’000 

326  
5,598  
-  
19  
______ 
5,943 
______ 

9,066 
4,027 
______ 
13,093 
______ 
19,036 

3,503 
1,513 
4,949 
______ 
9,965 
______ 

3,270 
______ 
3,270 
______ 
13,235 
______ 
5,801 
______ 

265  
5,889  
-  
19  
______ 
6,173 
______ 

6,755 
4,735 
______ 
11,490 
______ 
17,663 

2,842 
2,124 
5,166 
______ 
10,132 
______ 

3,288 
______ 
3,288 
______ 
13,420 
______ 
4,243 
______ 

318  
5,694 
- 
19 
______ 
6,031 
______ 

6,403  
6,273  
______ 
12,676  
______ 
18,707  

3,861  
1,830 
4,304 
______ 
9,995  
______ 

3,436  
______ 
3,436  
______ 
13,431  
______ 
5,276  
______ 

- 
- 
9,551 
- 
______ 
9,551 
______ 

52 
789 
______ 
841 
______ 
10,392 

492 
- 
- 
______ 
492  
______ 

3,120 
______ 
3,120 
______ 
3,612  
______ 
6,780  
______ 

- 
- 
10,113 
- 
______ 
10,113 
______ 

2 
479 
______ 
481 
______ 
10,594 

628  
- 
- 
______ 
628 
______ 

3,270 
______ 
3,270 
______ 
3,898 
______ 
6,696 
______ 

23 
24  

2,354 
5,654 
(46) 
(3,719) 
______ 
4,243 
______ 
______ 

2,354 
5,498 
151 
(2,202) 
______ 
5,801 
______ 
______ 

11,769  
89,926  
250 

(96,669)  
______ 
5,276  
______ 
______ 

2,354 
5,654 
- 

(1,228)  

______ 
6,780 
______ 
______ 

2,354 
5,498 
- 
(1,156) 
______ 
6,696 
______ 
______ 

-
-
9,893
-
______
9,893
______

-
2,352
______
2,352 
______
12,245

587 
-
-
______
587
______

3,167
______
3,167 
______
3,754
______
8,491
______

11,769
89,926 
-
(93,204)
______
8,491
______
______

Approved by the board and authorized for issue on 18 March 2015.

Barry K. Mence 
Director   

Arif Karimjee
Director

 
 
 
 
 
 
  
 
  
 
 
  
 
 
  
 
  
 
  
 
 
 
 
  
 
 
  
 
  
 
  
 
 
 
  
 
 
  
 
 
 
  
 
 
  
 
  
 
 
 
 
 
 
2 6 

FINANCIAL STATEMENTS

2 7

C O N S O L I D AT E D   A N D   C O M PA N Y   C A S H   F L O W   S TAT E M E N T S 

F O R   T H E   Y E A R   E N D E D   3 1   D E C E M B E R   2 0 1 4

Group 

Company 

Notes 

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000

Operating Activities

(Loss)/profit for the year 

(1,519) 

534 

488 

(2,105)

Adjustments for:
Finance income 
Finance costs 
Depreciation of property, plant and equipment 
Amortization and impairment of intangible assets 
Share-based payment expense 
Intra-group credits and charges 
Provisions against intra-group loans  

Operating cash flows before movements in working capital 
Decrease/(increase) in receivables 
(Decrease)/increase in payables 

Net cash generated from/(used in) operating activities 

Investing Activities

Finance income 
Purchases of property, plant and equipment 
Development costs capitalized 
Acquisition of subsidiary undertaking   
Net cash acquired with subsidiary undertaking   
Advance of loans to group companies    
Repayment of loans by group companies    

 Net cash (used in)/generated from investing activities 

Financing Activities

Drawdown/(repayment) of loan notes 
Increase in line of credit   
Expenses of capital reorganization    
Interest paid    

Net cash from financing activities 

Net increase/(decrease) in cash and cash equivalents 

Cash and cash equivalents at the beginning of the year 
Effect of foreign exchange rate changes 

Cash and cash equivalents at the end of the year  

18 

(12) 
429 
227 
2,076 
158 
- 
- 
–––––––– 
1,359 
2,003 
(314) 
–––––––– 
3,048 
–––––––– 

(27) 
445 
226 
1,923 
121 
- 
- 
–––––––– 
3,222 
(2,568) 
99 
–––––––– 
753 
–––––––– 

- 
330 
- 
- 
158 
(448) 
(1,043) 
–––––––– 
(515)  
(50) 
(137) 
–––––––– 
(702) 
–––––––– 

-
261
-
-
121
(482)
1,383
––––––––
(822) 
(2)
41 
––––––––
(783)
––––––––

12 
(176) 
(2,367) 
- 
- 
- 
- 
–––––––– 

27 
(227) 
(1,788) 
(58) 
69 
- 
- 
–––––––– 

- 
- 
- 
- 
- 
(1,486) 
2,974 
–––––––– 

-
-
-
-
-
(2,826)
1,926
––––––––

(2,531) 
–––––––– 

(1,977) 
–––––––– 

1,488 
–––––––– 

(900)
––––––––

92 
729 
- 
(395) 
–––––––– 
426 
–––––––– 
943 

(1,080) 
450 
(31) 
(413) 
–––––––– 
(1,074) 
–––––––– 
(2,298) 

- 
- 
- 
(295) 
–––––––– 
(295) 
–––––––– 
491 

-
-
(31)
(229)
––––––––
(260)
––––––––

(1,943) 

4,027 
(235) 
–––––––– 
4,735 
–––––––– 
–––––––– 

6,273 
52 
–––––––– 
4,027 
–––––––– 
–––––––– 

479 
(181) 
–––––––– 
789 
–––––––– 
–––––––– 

2,352
70 
––––––––
479
––––––––
––––––––

 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
2 6 

FINANCIAL STATEMENTS

2 7

C O N S O L I D AT E D   A N D   C O M PA N Y   S TAT E M E N T S   O F   C H A N G E S 

I N   E Q U I T Y   F O R   T H E   Y E A R   E N D E D   3 1   D E C E M B E R   2 0 1 4

Group 

At 1 January 2013 
Profit for the year      
Exchange differences on translation
   of foreign operations 

Total comprehensive income for the year 

Recognition of share-based payments 
Lapsing or expiry of share options   
Capital reorganization and reduction of capital 

At 1 January 2014 
Loss for the year      
Exchange differences on translation
   of foreign operations 

Total comprehensive income for the year 

Recognition of share-based payments 
Lapsing or expiry of share options 

At 31 December 2014 

Share 
Capital 
$’000 

Capital  Translation 
Reserve 
$’000 

Reserves 
$’000 

Retained 
Losses 
$’000 

11,769 
- 

89,926 
- 

250 
- 

(96,669) 
534 

- 
–––––––– 
- 
–––––––– 
- 
- 
(9,415) 
–––––––– 
2,354 
- 

- 
–––––––– 
- 
–––––––– 
- 
- 
–––––––– 
2,354 
–––––––– 
–––––––– 

- 
–––––––– 
- 
–––––––– 
121 
(729) 
(83,820) 
–––––––– 
5,498 
- 

- 
–––––––– 
- 
–––––––– 
158 
(2) 
–––––––– 
5,654 
–––––––– 
–––––––– 

(99) 
–––––––– 
(99) 
–––––––– 
- 
- 
- 
–––––––– 
151 
- 

(197) 
–––––––– 
(197) 
–––––––– 
- 
- 
–––––––– 
(46) 
–––––––– 
–––––––– 

- 
–––––––– 
534 
–––––––– 
- 
729 
93,204 
–––––––– 
(2,202) 
(1,519) 

- 
–––––––– 
(1,519) 
–––––––– 
- 
2 
–––––––– 
(3,719) 
–––––––– 
–––––––– 

Total
$’000

5,276
534

(99)
––––––––
435
––––––––
121
-
(31)
––––––––
5,801
(1,519)

(197)
––––––––
(1,716)
––––––––
158
-
––––––––
4,243
––––––––
––––––––

The translation reserve represents accumulated differences on the translation of assets and liabilities of foreign 
operations.  Retained losses represent accumulated trading losses, including amortization and impairment charges 
in respect of goodwill and intangible assets arising from past acquisitions, and the credit arising from the reduction of 
capital which became effective in November 2013.  Full details of the capital reserves and the capital reorganization and 
reduction of capital are set out in the Director’s Report and in Notes 23 and 24.

Company 

At 1 January 2013 
Loss and total comprehensive income for the year   
Recognition of share-based payments     
Lapsing or expiry of share options    
Capital reorganization and reduction of capital   

At 1 January 2014 
Profit and total comprehensive loss for the year   
Recognition of share-based payments    
Lapsing or expiry of share options    

At 31 December 2014 

Share 
Capital 
Capital  Reserves 
$’000 

$’000 

Retained 
Losses 
$’000 

11,769 
- 
-  
- 
(9,415) 
–––––––– 
2,354 
- 
- 
- 
–––––––– 
2,354 
–––––––– 
–––––––– 

89,926 
- 
121 
(729) 
(83,820) 
–––––––– 
5,498 
- 
158 
(2) 
–––––––– 
5,654 
–––––––– 
–––––––– 

(93,204) 
(1,885) 
- 
729 
93,204 
–––––––– 
(1,156) 
(74) 
- 
2 
–––––––– 
(1,228) 
–––––––– 
–––––––– 

Total
$’000

8,491
(1,885) 
121
-
(31)
––––––––
6,696
(74)
158
-
––––––––
6,780
––––––––
––––––––

 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
  
 
2 8 

NOTES TO THE FINANCIAL STATEMENTS

2 9

1 .   G E N E R A L   I N F O R M AT I O N

Sopheon plc ("the company") is a public limited company incorporated in England and Wales.  The address of its registered 
office and principal place of business is set out on page 14.  The principal activities of the company and its subsidiaries are 
described in Note 3.  The financial statements have been prepared in US Dollars and rounded to the nearest thousand.

2 .   S I G N I F I C A N T   A C C O U N T I N G   P O L I C I E S

The financial statements have been prepared in accordance with International Financial Reporting Standards and 
Interpretations issued by the International Accounting Standards Board as adopted by the European Union and those 
parts of the Companies Act 2006 which apply to companies preparing their financial statements under IFRS.  The principal 
accounting policies are set out below.  The policies have been applied consistently to all the years presented.

A number of new standards, amendments and interpretations to existing standards have been adopted by the group, but 
have not been listed, since they have no material impact on the financial statements.  The impact of IFRS 15 Revenues 
from Contracts with Customers, which will apply from reporting periods beginning on or after 1 January 2017, is still being 
assessed.  None of the other new standards, amendments and interpretations in issue but not yet effective are expected to 
have a material effect on the financial statements.

Change in Accounting Policies

The group’s financial statements have been presented in US Dollars. In prior periods, the financial statements were 
presented in British Pounds Sterling.  This change is intended to reduce the effect of currency movements on reported 
revenues, and to better reflect the underlying nature of the business.  Approximately two-thirds of the group’s revenue and 
operating costs are denominated in US Dollars.  The 2013 and 2012 balance sheets for the group and company have been 
retranslated into US Dollars at 1.6528 and 1.6168 US Dollars to British Pounds Sterling, and the results for 2013 have been 
retranslated into US Dollars at 1.5699 US Dollars to British Pounds Sterling.  Retranslation differences arising have been 
recognised in the translation reserve. 

Going Concern

The financial statements have been prepared on a going concern basis.  In reaching their assessment, the directors have 
considered a period extending at least 12 months from the date of approval of these financial statements.  This assessment 
has included consideration of the forecast performance of the business for the foreseeable future, the cash and financing 
facilities available to the group, and the repayment terms in respect of the group’s borrowings, including the potential of 
having to repay convertible loan stock in January 2017. 

During 2014, the group achieved revenues of $18.3m and a loss before tax of $1.5m.  This represents a reduced 
performance compared to the previous year, which culminated 5 years of growth.  The directors believe this was a 
temporary pause in the development of the business.  Coming into 2015, the group’s sales pipeline remains active, and 
accordingly, the directors remain positive about the prospects for the business.

On 25 February 2014 the group established facilities with Silicon Valley Bank (“SVB”) to replace expiring facilities from 
BlueCrest Capital Finance.  The new facilities comprised a term loan of $0.5m repayable in 36 equal monthly instalments, 
and a $3m revolving line of credit, which will come up for renewal in February 2016.  The facilities are subject to covenants 
based on operating results and working capital ratios. 

In addition, the group has a £2,000,000 convertible loan outstanding to key investors including members of the board and 
management.  The current terms of the loan call for repayment or conversion by 31 January 2017.

Notwithstanding the group’s funding position, the time-to-close and the order value of individual sales continues to vary 
considerably as exemplified by 2014’s results.  When combined with the relatively low-volume and high-value nature of the 
group’s business, these are factors which constrain the ability to accurately predict revenue performance.  If sales fall short 
of expectations, there is a risk that the group may be obliged to seek additional funding. 

The directors have concluded that the circumstances set forth above represent uncertainties.  However they believe that 
taken as a whole, the factors described above enable the group to continue as a going concern for the foreseeable future.  
The financial statements do not include the adjustments that would be required if the company or group were unable to 
continue as a going concern.

 
 
 
 
 
   
2 8 

NOTES TO THE FINANCIAL STATEMENTS

2 9

Basis of Consideration

The consolidated financial statements incorporate the financial statements of the parent company Sopheon plc and the 
financial statements of the subsidiaries as shown in Note 15 of the consolidated financial statements.  The financial 
statements of all the group companies are prepared using uniform accounting policies.   All intra-group transactions, 
balances, income and expenses are eliminated on consolidation. 

Business Combinations

The acquisition of subsidiaries is accounted for within the consolidated financial statements using the purchase method.  
No material business combinations have been entered into since that date.  The cost of the acquisition is measured at the 
aggregate of the fair values at the date of exchange, of assets given, liabilities incurred or assumed, and equity instruments 
issued by the group in exchange for control of the entity being acquired, together with any costs directly attributable to the 
business combination.  The results of the acquired entities are included in the consolidated income statement from the date 
on which effective control is obtained.  The identifiable assets, liabilities and contingent liabilities of the entity being acquired 
that meet the conditions for recognition are recognized at their fair values of the date of acquisition.

Identifiable intangible assets are capitalized at fair value as at the date of acquisition.  The useful lives of these intangible 
assets are assessed and amortization is charged on a straight-line basis, with the expense taken to the income statement 
within sales and marketing expense (in respect of customer relationships) and research and development expense (in 
respect of IPR and technology).  Intangible assets are tested for impairment when a trigger event occurs.  Useful lives are 
also examined on an annual basis and adjustments, where applicable, are made on a prospective basis.

Goodwill

Goodwill arising on the acquisition of a subsidiary represents the excess of the cost of acquisition over the group’s interest 
in the net fair value of the identifiable assets, liabilities and contingent liabilities of the subsidiary at the date of acquisition.  
Goodwill is initially recognized at cost and is subsequently measured at cost less any accumulated impairment losses.

For the purposes of impairment testing, goodwill is allocated to those cash-generating units of the group expected to benefit 
from the synergies of the business combination.  Cash-generating units to which goodwill has been allocated are tested 
for impairment annually, or more frequently when there is an indication that the unit may be impaired.  If the recoverable 
amount of the cash-generating unit is less than the carrying value of the unit, the impairment loss is allocated firstly to 
reduce the carrying cost of any goodwill allocated to the unit and then to any other assets of the unit pro rata to the carrying 
value of each asset of the unit.  An impairment loss recognized for goodwill is not reversed in a subsequent period.

Revenue Recognition

Revenue is measured at the fair value of the consideration received or receivable and represents amounts receivable for 
goods and services provided in the normal course of business, net of discounts and sales-related taxes.

Sales of software licenses are recognized once no significant obligations remain owing to the customer in connection with 
such license sale.  Such significant obligations could include giving a customer a right to return the software product without 
any preconditions, or if the group is unable to deliver a material element of the software product by the balance sheet date.  

Revenues relating to maintenance, hosting and post-contract support agreements are deferred and recognized over the 
period of the agreements.

Revenues from implementation and consultancy services are recognized as the services are performed, or in the case of 
fixed price or milestone-based projects, on a percentage basis as the work is completed and any relevant milestones are 
met, using latest estimates to determine the expected duration and cost of the project.

Leases

Assets held under finance leases are recognized as assets of the group at their fair value at the inception of the lease or, if 
lower, at the net present value of the minimum lease payments.  The corresponding liability to the lessor is included in the 
balance sheet as a finance lease obligation.  Lease payments are apportioned between finance charges and reduction of 
the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability.  Finance charges 
are charged to the income statement.

 
3 0 

NOTES TO THE FINANCIAL STATEMENTS

3 1

Rentals payable under operating leases are charged to the income statement on a straight-line basis over the term of the 
relevant lease.

Interest on Borrowings

All interest on borrowings is recognized in the income statement in the period in which it is incurred.

Retirement Benefit Costs

Payments to defined contribution retirement benefit plans are charged as an expense as they fall due.  The group does 
not operate any defined benefit retirement benefit plans.

Foreign Currencies

The individual financial statements of each group entity are presented in the currency of the primary economic 
environment in which the entity operates (its functional currency).  In preparing the financial statements of the individual 
entities, transactions in currencies other than the entity’s functional currency (foreign currencies) are recorded at rates 
approximating to the transaction rates.  At each balance sheet date, monetary items denominated in foreign currencies 
are retranslated at the rates prevailing on the balance sheet date.  Exchange differences arising on the settlement of 
monetary items, and on the retranslation of monetary items, are included in the income statement for the period. 

For the purpose of presenting consolidated financial statements, the assets and liabilities of the group’s foreign 
operations are expressed in US Dollars using exchange rates prevailing on the balance sheet date.  Income and expense 
items (including comparatives) are translated at the average exchange rates for the period.  Exchange differences 
arising (including exchange differences on intra-group loans where there is no intention that these should be settled) are 
classified as equity and transferred to the group’s translation reserve.  

On disposal of a foreign operation the cumulative exchange differences recognized in the foreign exchange reserve 
relating to that operation up to the date of disposal are transferred to the income statement as part of the profit or loss on 
disposal.

Deferred Tax

Deferred tax is recognized on differences between the carrying amounts of assets and liabilities in the financial 
statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the 
balance sheet liability method.  Deferred tax liabilities are generally recognized for all taxable temporary differences, but 
deferred tax assets are recognized only to the extent that it is probable that taxable profits will be available against which 
deductible temporary differences can be utilized.

Deferred tax is calculated at tax rates that have been enacted or substantively enacted at the balance sheet date, and 
that are expected to apply in the period when the liability is settled or the asset realized.  Deferred tax is charged or 
credited to profit or loss, except when it relates to items charged or credited directly to equity, in which case the deferred 
tax is also dealt with in equity.

Property, Plant and Equipment

Computer equipment and fixtures and fittings are stated at cost less accumulated depreciation and any accumulated 
impairment losses.  Depreciation is charged so as to write off the costs of assets over their estimated useful lives, using 
the straight-line method.

Assets held under finance leases are depreciated over their expected useful lives on the same basis as owned assets, 
or, when shorter, over the term of the relevant lease.

The gain or loss arising on the disposal or retirement of an item of property, plant and equipment is determined as the 
difference between the sale proceeds and the carrying amount of the asset and is recognized in the income statement.

The following rates are used for the depreciation of property, plant and equipment:

Computer equipment 
Furniture and fittings 

20-33 percent on a straight-line basis
20-25 percent on a straight-line basis

 
 
 
3 0 

NOTES TO THE FINANCIAL STATEMENTS

3 1

Investments

Investments in subsidiaries within the company balance sheet are stated at cost less impairment.  Impairment tests are 
undertaken whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.  
Where the carrying value of an investment exceeds its recoverable amount, the investment is written down accordingly.

Internally Generated Intangible Assets (Research and Development Expenditure)

Development expenditure on internally developed software products is capitalized if it can be demonstrated that:

• it is technically feasible to develop the product;
• adequate resources are available to complete the development;
• there is an intention to complete and sell the product;
• the group is able to sell the product;
• sales of the product will generate future economic benefits; and
• expenditure on the product can be measured reliably.

Development costs not satisfying the above criteria and expenditure on the research phase of internal projects are 
recognized in the income statement as incurred.  Capitalization of a particular activity commences after proof of concept, 
requirements and functional concept stages are complete. 

Capitalized development costs are amortized over the period over which the group expects to benefit from selling the product 
developed.  This has been estimated to be four years from the date of code-finalization of the applicable software release.  
The amortization expense in respect of internally generated intangible assets is included in research and development costs.

Impairment of Tangible and Intangible Assets (Excluding Goodwill)

At each balance sheet date, the group reviews the carrying amounts of its tangible and intangible assets to determine 
whether there is any indication that those assets have suffered an impairment loss.  If any such indication exists, the 
recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).  Where it is not 
possible to estimate the recoverable amount of an individual asset, the group estimates the recoverable amount of the cash-
generating unit to which the asset belongs.

Recoverable amount is the higher of the fair value less costs to sell and value in use.  In assessing the value in use, the 
estimated future cash flows are discounted to their net present value using a pre-tax discount rate that reflects current market 
assessments of the time value of money and the risks specific to the asset.

If the recoverable amount of an asset or cash-generating unit is estimated to be less than its carrying amount, the carrying 
amount of the asset or cash-generating unit is reduced to its recoverable amount.  An impairment loss is recognized 
immediately in the administrative expenses line item in the income statement.

Where an impairment loss subsequently reverses, the carrying value of the asset or cash-generating unit is increased to 
the revised recoverable amount, but so that the increased carrying amount does not exceed the carrying amount which 
would have been determined had no impairment loss been recognized in prior years.  A reversal of an impairment loss is 
recognized immediately in profit or loss. 

Share-based Payments

The group issues equity-settled share-based payments to certain employees.  Equity-settled share-based payments are 
measured at fair value (excluding the effect of non-market-based vesting conditions) at the date of grant.  The fair value 
determined at the date of grant is expensed on a straight-line basis over the vesting period, based on the group’s estimate of 
the shares that will eventually vest and adjusted for the effect of non-market-based vesting conditions.

Fair value is measured by the binomial option-pricing model.  The expected life used in the model had been adjusted, based 
on management’s best estimate, for the effects of non-transferability, exercise restrictions and behavioral considerations.

As set out in Note 24, the group has also issued warrants to certain financing institutions which are also treated as equity-
settled share-based payments.

 
 
3 2 

NOTES TO THE FINANCIAL STATEMENTS

3 3

Significant Accounting Estimates and Judgments

Management is required to make judgments, estimates and assumptions about the carrying amounts of assets and 
liabilities that are not readily apparent from other sources.  The estimates and associated assumptions are based 
on historical experience and other factors that are considered to be relevant.  Estimates and judgments adopted for 
property plant and equipment, externally acquired intangible assets and internally generated intangible assets are 
dealt with in the accounting policy notes set forth above that relate to these areas.  Actual results may differ from these 
estimates, and accordingly they are reviewed on an ongoing basis.  Revisions to accounting estimates are recognized 
in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and 
future periods if the revision affects both current and future periods.

Financial Instruments

1. Financial Assets

The group’s financial assets fall into the category of loans and receivables.  The group does not have any financial 
assets in the categories of fair value through profit and loss or available for sale.  The group has not classified any of 
its financial assets as held to maturity. 

Unless otherwise indicated, the carrying values of the group’s financial assets are a reasonable approximation of their 
fair values.

Loans and Receivables

These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active 
market.  They arise principally through the provision of goods and services (e.g. trade receivables) but also include 
cash and cash equivalents and other types of contractual monetary asset.  They are initially recognized at fair value 
plus transaction costs that are directly attributable to the acquisition or issue and subsequently carried at amortized 
cost using the effective interest rate method, less provision for impairment. The effect of discounting on these financial 
instruments is not considered material.

Impairment provisions are recognized when there is objective evidence (such as significant financial difficulties, default 
or significant delay in payment on the part of the counter-party) that the group will be unable to collect all the amounts 
due under the terms of the receivable, the amount of such provision being the difference between the net carrying 
amount and the present value of the future expected cash flows associated with the receivable.  For trade receivables, 
such provisions are recorded in a separate allowance account with the loss being recognized within administrative 
expenses in the income statement.  On confirmation that the trade receivable will not be collectable, the gross carrying 
value of the asset is written off against the associated provision.

2. Financial Liabilities

The group classifies its financial liabilities in the category of financial liabilities at amortized cost. 

Financial liabilities measured at amortized cost include:

•  Trade payables and other short-dated monetary liabilities, which are initially recognized at fair value and 

subsequently carried at amortized cost using the effective interest rate method.

•  Bank and other borrowings (including the host debt element of the convertible loan noted above), which are initially 
recognized at fair value net of any transaction costs directly attributable to the acquisition of the instrument.  Such 
interest-bearing liabilities are subsequently measured at amortized cost using the effective interest rate method, 
which ensures that the interest expense over the period to repayment is at a constant rate on the balance of 
the liability carried in the balance sheet.  Interest expense in this context includes initial transaction costs and 
premiums payable on redemption, as well as any interest payable while the liability is outstanding.

Unless otherwise indicated, the carrying values of the group’s financial liabilities measured at amortized cost represent 
a reasonable approximation of their fair values.

 
3 2 

NOTES TO THE FINANCIAL STATEMENTS

3 3

3. Convertible Loan Stock

The host debt element of convertible loan stock is treated as a financial liability measured at amortized cost as further 
described above. The equity component of convertible loan stock arising on issue is reclassified from debt to capital 
reserves.

4. Share Capital

Financial instruments issued by the group are treated as equity only to the extent that they do not meet the definition 
of a financial liability.  The group’s ordinary shares are classified as equity.  For the purpose of the disclosures given in 
Note 23 the group considers its capital to comprise its ordinary share capital, special reserve and equity reserve less its 
accumulated retained loss.

3 .   S E G M E N TA L   A N A LY S I S

All of the group’s revenue in respect of the years ended 31 December 2014 and 2013 was derived from the design, 
development and marketing of software products with associated implementation and consultancy services, as more 
particularly described in the Strategic and Financial Reports.  For management purposes, the group is organized 
geographically across two principal operating segments, which can be expressed geographically.  The first segment is 
North America, and the second Europe.  Information relating to these two segments is given below. 

The information in the following table relating to external revenues includes analysis both by location of customer and 
by location of operations.  The information relating to other items provides analysis by location of operations only.   
Inter-segment revenues are priced on an arm’s length basis.

Year ended 31 December 2014 

Income Statement
External revenues – by location of operations    
Operating profit/(loss) before interest and tax    
Finance income      
Finance expense     
Profit/(loss) before tax     
Depreciation and amortization   
EBITDA     

Balance Sheet 
Fixed asset additions    
Capitalization of internally generated development costs   
Total assets     
Total liabilities     

Year ended 31 December 2013 

Income Statement
External revenues – by location of operations 
Operating profit/(loss) before interest and tax    
Finance income      
Finance expense     
Profit/(loss) before tax     
Depreciation, amortization and impairment charges   
EBITDA     

Balance Sheet 
Fixed asset additions     
Capitalization of internally generated development costs   
Total assets     
Total liabilities     

North 
  America 
$’000 

Europe 
$’000 

Total
$’000

12,544 
424 
-  
(95) 
329 
(2,239) 
2,664 
–––––––– 

132 
2,367 
13,766 
(8,088) 
–––––––– 
–––––––– 

North 
America 
$’000 

5,752 
(1,526) 
12 
(334) 
(1,848) 
(64) 
(1,463) 
–––––––– 

44 
- 
3,897 
(5,332) 
–––––––– 
–––––––– 

18,296
(1,102)
12
(429) 
(1,519) 
(2,303) 
1,201
––––––––

176
2,367
17,663
(13,420) 
––––––––
––––––––

Europe 
$’000 

Total
$’000

13,984 
1,137  
-  
(182)  
953  
(2,091)  
3,155  
–––––––– 

6,857 
(184)  
27  
(263)  
(419)  
(58)  
(126)  
–––––––– 

20,841
953 
27
(445) 
534 
(2,149)
3,029
––––––––

131 
1,788 
13,289  
(7,148)  
–––––––– 
–––––––– 

96 
 -  
5,747  
(6,087)  
–––––––– 
–––––––– 

227
1,788
19,036
(13,235)
––––––––
––––––––

 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 4 

NOTES TO THE FINANCIAL STATEMENTS

3 5

One customer accounted for approximately 10 percent of the group’s revenues in 2014.  A different customer 
accounted for approximately 8 percent or more of the group’s revenue in 2013.  In 2014 the customer was within the 
North America segment based on location of operations (2013: Europe segment). 

External revenues in 2014 exclude inter-segmental revenues which amounted to $1,696,000 (2013: $2,148,000) for 
North America and $370,000 (2013: $349,000) for Europe.

Revenues attributable to customers in North America in 2014 amounted to $11,433,000 (2013: $12,507,000).  Revenue 
attributable to customers in the rest of the world amounted to $6,863,000 (2013: $8,335,000) of which $5,775,000 
(2013: $6,754,000) was attributable to customers in Europe.  

4 .   E B I T D A   A N D   R E V E N U E   V I S I B I L I T Y

EBITDA

The directors consider that EBITDA, which is defined as earnings before interest, tax, depreciation and amortization, is 
an important measure, since it is widely used by the investment community.  It is calculated as follows:

 (Loss)/profit for the year after tax 

Interest payable 
Interest receivable  
Amortization of intangible assets 
Depreciation of property, plant and equipment 
Income tax expense 

EBITDA 

Revenue Visibility

2014 
$’000 

2013
$’000

(1,519) 

534 

429 
(12) 
2,076 
227 
- 
  –––––––– 
1,201 
  –––––––– 
  –––––––– 

445 
(27) 
1,851 
226 
-
––––––––
3,029
––––––––
––––––––

Another performance indicator used by the group and referred to in narrative descriptions of the group’s performance 
is revenue visibility.  At any point in time it comprises revenue expected from (i) closed license orders, including those 
which are contracted but conditional on acceptance decisions scheduled later in the year; (ii) contracted services 
business delivered or expected to be delivered in the year; and (iii) recurring maintenance, hosting and rental 
streams.  The visibility calculation does not include revenues from new sales opportunities expected to close during the 
remainder of the year.

5 .   P R O F I T   F O R   T H E   Y E A R

The profit for the year has been arrived at after charging/(crediting): 

Continuing Operations

Net foreign exchange losses/(gains)   
Research and development costs (excluding amortization)   
Amortization of intangible assets   
Impairment of intangible assets   
Depreciation of property, plant and equipment   
Operating lease rentals – land and buildings   
Operating lease rentals – other   

2014 
$’000 

2013
$’000

42  
2,367  
2,076  
-  
227  
587  
120  
  –––––––– 
  –––––––– 

(106)
2,972
1,851
72
226 
497
118
––––––––
––––––––

Net foreign exchange gains or losses arise on the translation of cash and trade balances held in currencies other than 
the functional currency of the entity concerned and are accordingly included in administration expense.

 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 4 

NOTES TO THE FINANCIAL STATEMENTS

3 5

6 .   A U D I T O R S ’  R E M U N E R AT I O N   

During the year the group obtained the following services from its auditors and associated firms.  Fees for the audit 
of the parent, pursuant to legislation, are not segregated from those for the group and are included in the amounts 
disclosed.  

Audit of the financial statements of the group 
Audit of the financial statements of the UK subsidiary 
Review of interim financial information 
Audit of US pension plan 
Tax services 

7 .   S TA F F   C O S T S

Wages and salaries 
Social security costs 
Pension contributions 
Employee benefits expense 

2014 
$’000 

2013
$’000

84 
7 
16 
- 
15 
  –––––––– 
  –––––––– 

76
7
16
8
22
––––––––
––––––––

2014 
$’000 

2013
$’000

11,390 
1,019 
234 
951 
––––––– 
13,594 
–––––––– 
–––––––– 

11,700 
1,064 
243 
808
––––––– 
13,815 
––––––––
––––––––

Included within the above are staff costs capitalized as development expenditure amounting to $2,367,000  
(2013: $1,788,000).  Included within wages and salaries are bonus and sales commission costs amounting to $455,000 
(2013: $945,000). 

The average monthly number of employees during the year was made up as follows:

Development and operations 
Sales and management 

2014 
Number 

2013
Number 

79 
35 
––––––– 
114 
–––––––– 
–––––––– 

78
36
––––––– 
114 
––––––––
––––––––

 The above staff costs and the numbers of employees during the year include the executive directors.

The remuneration of all directors was as follows:

Fees and emoluments 
Pension contributions 

2014 
$’000 

2013
$’000

836 
21 
  –––––––– 
857 
  –––––––– 
  –––––––– 

856
22
––––––––
878
––––––––
––––––––

No director exercised share options during the year (2013: None).  Pension contributions are to personal defined 
contribution schemes and have been made for three directors (2013: three) who served during the year.

Full details of directors’ remuneration are disclosed in the Report on Directors’ Remuneration on page 15.

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
3 6 

NOTES TO THE FINANCIAL STATEMENTS

3 7

8 .   F I N A N C E   I N C O M E

Income on financial assets measured at amortized cost
    Interest income on bank deposits 

9 .   F I N A N C E   E X P E N S E

Interest expense on financial liabilities measured at amortized cost Interest on borrowings  

1 0 .   I N C O M E   TA X   E X P E N S E

Income tax expense for the year – current tax 

The charge for the year can be reconciled to the accounting (loss)/profit as follows:

(Loss)/profit before tax    

2014 
$’000 

2013
$’000

12 
–––––––– 
–––––––– 

27
––––––––
––––––––

2014 
$’000 
(429) 
–––––––– 
–––––––– 

2013
$’000 
(445)
––––––––
––––––––

2014 
$’000 

2013
$’000

- 
–––––––– 
–––––––– 

-
––––––––
––––––––

2014 
$’000 

2013
$’000

(1,519)  

–––––––– 
–––––––– 

534
––––––––
––––––––

Tax credit/(charge) at the UK corporation tax rate of 21.5% (2013: 23.25%)     
Adjustment for differing rates of corporate taxation in overseas jurisdictions   
Tax effect of expenses that are not deductible in determining taxable losses 
Temporary differences arising from the capitalization and transfer of development investments     
Losses for the year not relievable against current tax    
Utilization of prior year losses      

Income tax expense for the year      

There is no tax arising on other comprehensive income.

327  
143 
(91) 
280  
(659)  
-  
–––––––– 
-  
–––––––– 
–––––––– 

(124)
(96) 
(115)
249 
-
86
––––––––
-
––––––––
––––––––

The group has an unrecognized deferred tax asset arising from its unrelieved trading losses, which has not been 
recognized owing to uncertainty as to the level and timing of taxable profits in the future.  The unrecognized deferred 
tax asset is made up as follows:

Shortfall of tax depreciation compared to book depreciation 
Effect of timing differences arising from capitalization
   of internally generated development costs 
Unrelieved trading losses 

Unrecognized deferred tax asset 

2014 
$’000 

2013
$’000

194  

225 

(1,704) 
21,307 
–––––––– 
19,797 
–––––––– 
–––––––– 

(1,602)
21,569
––––––––
20,192
––––––––
––––––––

At 31 December 2014, tax losses estimated at $73m were available to carry forward by the Sopheon group, arising 
from historic losses incurred.  These losses represent a potential deferred tax asset of $21.3m, based on the tax rates 
currently applicable in the relevant tax jurisdictions.

Of these tax losses, an aggregate amount of $11.7m (representing $4.1m of the potential deferred tax asset) represents 
pre-acquisition tax losses of Sopheon Corporation (Minnesota) and Alignent Software, Inc.  The future utilization of 
these losses may be restricted under Section 382 of the US Internal Revenue Code, whereby the ability to utilize net 
operating losses arising prior to a change of ownership is limited to a percentage of the entity value of the corporation 
at the date of change of ownership.  

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 6 

NOTES TO THE FINANCIAL STATEMENTS

3 7

11 .   P R O F I T   D E A LT   W I T H   I N   T H E   F I N A N C I A L   S TAT E M E N T S   O F   T H E

PA R E N T   C O M PA N Y

The profit dealt with in the financial statements of the parent company for the year ended 31 December 2014 was 
$488,000 (2013: loss of $2,105,000).  Advantage has been taken of Section 408 of the Companies Act 2006 not to 
present an income statement for the parent company.

1 2 .   ( L O S S ) / E A R N I N G S   P E R   S H A R E 

Profit after tax 

Weighted average number of ordinary shares for the purpose of basic earnings per share 

2014 
$’000 

2013
$’000

(1,519) 
  –––––––– 
  –––––––– 

534
––––––––
–––––––– 

’000s 
7,279 
  –––––––– 
  –––––––– 

’000s
7,279 
––––––––
––––––––

The profit attributable to ordinary shareholders and the weighted average number of ordinary shares for the purpose of 
calculating the diluted earnings per ordinary share are the same as those used for calculating the basic earnings per 
ordinary share in both 2014 and 2013.  This is (i) because the exercise of conversion rights attaching to the convertible 
loan stock (details of which are set out in Note 20),  would have the effect of reducing the loss per share or increasing 
earnings per ordinary share (by virtue of the saving of loan stock interest, which would otherwise be payable) and are 
therefore not dilutive; and (ii) because the warrants to subscribe for 25,138 ordinary shares and the 636,190 share 
options to subscribe for ordinary shares (details of which are set out in Notes 23 and 27), have a strike price above the 
average market price for the year.

1 3 .   P R O P E R T Y,   P L A N T   A N D   E Q U I P M E N T

Group 

Cost
At 1 January 2013    
Additions    
Exchange differences    

At 1 January 2014    
Additions    
Exchange differences    

At 31 December 2014    

Accumulated Depreciation
At 1 January 2013   
Depreciation charge for the year    
Exchange differences    

At 1 January 2014   
Depreciation charge for the year    
Exchange differences    

At 31 December 2014   

Carrying Amount  
At 31 December 2014 

At 31 December 2013 

Company
The company has no property, plant and equipment.

  Computer 
 Equipment 
$’000 

Furniture
& Fittings 
$’000 

1,455 
166 
7 
  –––––––– 
1,628 
168 
(20) 
  –––––––– 
1,776 
  –––––––– 

1,190 
191 
3 
  –––––––– 
1,384 
195 
(15) 
  –––––––– 
1,564 
  –––––––– 

302 
61 
5 
–––––––– 
368 
8 
(10) 
–––––––– 
366 
–––––––– 

249 
35 
2 
–––––––– 
286 
32 
(5) 
–––––––– 
313 
–––––––– 

Total
$’000

1,757
227
12
––––––––
1,996
176
(30)
––––––––
2,142
––––––––

1,439
226
5
––––––––
1,670
227
(20)
––––––––
1,877
––––––––

212 
  –––––––– 
  –––––––– 
244 
  –––––––– 
  –––––––– 

53 
–––––––– 
–––––––– 
82 
–––––––– 
–––––––– 

265
––––––––
––––––––
326
––––––––
––––––––

 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 8 

NOTES TO THE FINANCIAL STATEMENTS

3 9

1 4 .   I N TA N G I B L E   A S S E T S

Development
Costs 

  (Internally  Technology 
 Generated) 
$’000 

Customer
and IPR  Relationships 
$’000 

$’000 

Goodwill 
$’000 

Total
$’000

Cost
At 1 January 2013  
Additions (internally generated)  
Acquisition in 2013  

At 1 January 2014  
Additions (internally generated)  
Amounts written off  

At 31 December 2014 

Amortization
At 1 January 2013  
Charge for the year  

At 1 January 2014  
Charge for the year  
Amounts written off  

At 31 December 2014  

Accumulated Impairment Losses
At 1 January 2013  
Impairment losses in year  

At 1 January 2014  
Amounts written off  

At 31 December 2014 

Carrying Amount
At 31 December 2014 

At 31 December 2013 

1,394 
13,500 
-  
1,788  
-  
-  
  ––––––––  –––––––– 
1,394 
-  
(1,394)  

15,288 
2,367  
-  
  ––––––––  –––––––– 
- 
  ––––––––  –––––––– 

17,655 

8,908 
1,804  

975 
-  
  ––––––––  –––––––– 
975 
-  
(975)  

10,712 
2,076  
-  
  ––––––––  –––––––– 
- 
  ––––––––  –––––––– 

12,788 

419 
- 
-  
-  
  ––––––––  –––––––– 
419  
-  
(419)  
-  
  ––––––––  –––––––– 
- 
  ––––––––  –––––––– 

- 

4,867 

- 
  ––––––––  –––––––– 
  ––––––––  –––––––– 
- 
  ––––––––  –––––––– 
  ––––––––  –––––––– 

4,576 

2,614 
-  
-  
–––––––– 
2,614 
-  
(2,614)  

–––––––– 
- 
–––––––– 

1,371 
47  
–––––––– 
1,418 
-  
(1,418)  

–––––––– 
- 
–––––––– 

1,124 
72  
–––––––– 
1,196  
(1,196)  

–––––––– 
- 
–––––––– 

983 
-  
39  
–––––––– 
1,022 
-  
-  
–––––––– 
1,022 
–––––––– 

- 
-  
–––––––– 
- 
-  
-  
–––––––– 
- 
–––––––– 

- 
-  
–––––––– 
-  
-  
–––––––– 
- 
–––––––– 

18,491
1,788
39
––––––––
20,318
2,367
(4,008)
––––––––
18,677 
––––––––

11,254
1,851
––––––––
13,105
2,076
(2,393) 

––––––––
12,788
––––––––

1,543
72
––––––––
1,615
(1,615) 

––––––––
- 
––––––––

- 
–––––––– 
–––––––– 
- 
–––––––– 
–––––––– 

1,022 
–––––––– 
–––––––– 
1,022 
–––––––– 
–––––––– 

5,889
––––––––
–––––––– 
5,598
––––––––
–––––––– 

The amortization period for the internally generated development costs relating to the group’s software products is four 
years.  The amortization periods for (a) technology & IPR and (b) customer relationships, arising from the acquisition of 
Alignent Software, Inc. in June 2007, were four years and eight years respectively, and have now been written off in full. 
Goodwill is not amortized.  The residual goodwill arising on the acquisition of Alignent is attributable to the enhanced 
market position of each of the group’s operating segments, due to the completeness of the solution that Sopheon can 
offer the market.  The recoverable amount of the goodwill can be underpinned on a value in use basis by the expected 
performance of the group’s operating segments, each of which is treated as a separate cash generating unit.  Goodwill 
primarily relates to the North American operating segment.

The valuation used for this purpose is based on cash-flow projections for the next five years, and thereafter for an 
indefinite period at a growth assumption of 3 percent.  The discount rate used was 14.6 percent.  Sensitivity analysis 
performed on these projections demonstrates significant valuation headroom above the carrying value of goodwill.  The 
same discount and growth rates were used for the valuation conducted in respect of 2013. 

Company
The company has no intangible assets.

 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3 8 

NOTES TO THE FINANCIAL STATEMENTS

3 9

1 5 .   I N V E S T M E N T   I N   S U B S I D I A R I E S

At 31 December 2012 and at 31 December 2013

At cost less amounts provided
At 31 December 2013    
Exchange difference    

At 31 December 2014    

  Company
$’000

10,113  
(562)
  ––––––––
9,551
––––––––
––––––––

Details of the company’s subsidiaries at 31 December 2014 are set out below.  Companies marked with an asterisk (*) 
are held via Sopheon UK Ltd and those with an obelus (†) are held via Orbital Software Holdings plc.  The common 
stock of Alignent Software, Inc. and Sopheon Corporation, Minnesota, USA are held by Sopheon Corporation, Delaware, 
USA.  The share capital of Sopheon Corporation, Delaware, USA and Sopheon GmbH are held by Sopheon NV.

Name of Company 
Place of Incorporation 

Sopheon Corporation  
Minnesota, USA   

Sopheon Corporation  
Delaware, USA    

Alignent Software, Inc.  
California, USA

Sopheon NV  
The Netherlands   

Sopheon UK Ltd  
United Kingdom

Sopheon GmbH  
Germany 

Orbital Software Holdings plc  
United Kingdom

Orbital Software Inc.†  
Delaware, USA   

Sopheon Edinburgh Ltd†  
United Kingdom   

Orbital Software Europe Ltd†  
United Kingdom   

Network Managers (UK) Ltd*  
United Kingdom   

AppliedNet Ltd*  
United Kingdom

Future Tense Ltd*  
United Kingdom

Polydoc Ltd  
United Kingdom

Nature of Ownership 
Interest 

Proportion of 
Voting Rights Held

Nature of Business

Common Stock  

100%  

Software sales and services 

Common Stock  

100%  

Software development and sales

Common Stock  

100%  

Software sales and services

Ordinary Shares  

100%  

Software sales and services

Ordinary Shares  

100%  

Software sales and services

Ordinary Shares  

100%  

Software sales and services

Ordinary Shares  

100%  

Holding company

Common Stock  

100%  

Dormant

Ordinary Shares  

100%  

Dormant

Ordinary Shares  

100%  

Dormant

Ordinary Shares  

100%  

Dormant

Ordinary Shares  

100%  

Dormant

Ordinary Shares  

100%  

Dormant

Ordinary Shares  

100%  

Dormant

Applied Network Technology Ltd*  
United Kingdom 

Ordinary Shares  

100%  

Employee Share Ownership
Trust

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 0 

NOTES TO THE FINANCIAL STATEMENTS

4 1

1 6 .   O T H E R   R E C E I VA B L E

Other receivable 

  Group 

 Company

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000

19 
 –––––––– 
 –––––––– 

19 
–––––––– 
–––––––– 

- 
–––––––– 
–––––––– 

-
––––––––
––––––––

The other receivable represents a deposit paid in respect of a property leased by the group.

1 7 .   T R A D E   A N D   O T H E R   R E C E I VA B L E S

Trade receivables   
Other receivables   

Total receivables 
Prepayments 
Accrued income 

  Group 

 Company

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000 

6,072 
9 
 –––––––– 
6,081 
545 
129 
 –––––––– 
6,755 
 –––––––– 
 –––––––– 

7,962 
21 
–––––––– 
7,983 
572 
511 
–––––––– 
9,066 
–––––––– 
–––––––– 

- 
- 
–––––––– 
- 
52 
- 
–––––––– 
52 
–––––––– 
–––––––– 

-
2
––––––––
2
-
-
––––––––
2
––––––––
––––––––

Trade and other receivables are stated net of allowances totaling $Nil (2013: $Nil) for estimated irrecoverable amounts.  
The directors consider that the carrying amount of trade and other receivables approximates to their fair value. 

A full provision has been made against amounts totaling $62,870,000 (2013: $67,565,000) owed to the company by 
subsidiary undertakings, which are due after more than one year and are subordinated to the claims of all other creditors.

1 8 .   C A S H   A N D   S H O R T- T E R M   B A N K   D E P O S I T S

Cash at bank 
Short-term bank deposits 

  Group 

 Company

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000

3,944 
791 
 –––––––– 
4,735 
 –––––––– 
 –––––––– 

2,592 
1,435 
–––––––– 
4,027 
–––––––– 
–––––––– 

789 
- 
–––––––– 
789 
–––––––– 
–––––––– 

479
-
––––––––
479
––––––––
––––––––

Cash and short-term bank deposits comprise cash held by the group, bank current accounts and short-term bank deposit 
accounts with maturities of three months or less and bearing interest at variable rates.  The carrying amount of these 
assets represents a reasonable approximation to their fair value.

Included in cash at bank of the group is an amount of $38,000 (2013: $40,000) held by the group’s employee share 
ownership trust.

 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 0 

NOTES TO THE FINANCIAL STATEMENTS

4 1

1 9 .   T R A D E   A N D   O T H E R   PAYA B L E S

Trade payables 
Other payables 
Tax and social security costs 
Accruals 

  Group 

 Company

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000

833 
246 
336 
1,427 
 –––––––– 
2,842 
 –––––––– 
 –––––––– 

909 
255 
342 
1,997 
–––––––– 
3,503 
–––––––– 
–––––––– 

74 
160 
- 
258 
–––––––– 
492 
–––––––– 
–––––––– 

83
169 
-
376
––––––––
628
––––––––
––––––––

Trade payables principally comprise amounts outstanding for trade purchases and ongoing costs. 

The directors consider that the carrying amounts of trade and other payables represent a reasonable approximation to 
their fair values.

2 0 .   B O R R O W I N G S

Current Loans and Borrowings
Line of credit 
Loan notes (current portion) 

Total current loans and borrowings 

Non-current Loans and Borrowings
Loan notes (non-current portion) 
8% convertible loan stock 2017  

Total non-current loans and borrowings 

Total loans and borrowings 

a)  Line of Credit and Loan Notes

  Group 

 Company

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000

1,979 
145 
 –––––––– 
2,124 

1,250 
263 
–––––––– 
1,513 

- 
- 
–––––––– 
- 

- 
-
––––––––
-

168 
3,120 
 –––––––– 
3,288 
 –––––––– 
5,412 
 –––––––– 
 –––––––– 

- 
3,270 
–––––––– 
3,270 
–––––––– 
4,783 
–––––––– 
–––––––– 

- 
3,120 
–––––––– 
3,120 
–––––––– 
3,120 
–––––––– 
–––––––– 

-
3,270
––––––––
3,270 
––––––––
3,270
––––––––
––––––––

In February 2014 the group established new credit facilities with Silicon Valley bank.  The facilities comprise a $3m 
revolving line of credit and a term loan of $0.5m repayable in 36 equal installments.  Both facilities bear interest at rates 
of 2.75 percent above the Bank’s Prime Rate, resulting in a current effective rate of 6 percent.  The facilities are subject 
to covenants based on operating results, and in addition the drawdown mechanics and interest rates are subject to 
certain working capital ratios.

The directors consider that the carrying amounts for loan notes, and the line of credit, represent a reasonable 
approximation of the financial instruments’ fair values.

 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 2 

NOTES TO THE FINANCIAL STATEMENTS

4 3

b)  8 Percent Convertible Loan Stock 2017

The convertible loan stock is denominated in Sterling and bears interest at a fixed rate of 8 percent per annum.  The 
loan stock was issued at par in a nominal amount of £850,000 on 1 October 2009.  On 23 August 2012 the company 
made a further issue of loan stock in a nominal amount of £1,150,000.  Following this issue, whereby the aggregate 
liability at maturity of the loan stock increased from £850,000 to £2,000,000, the conversion price was 5p per ordinary 
share.  

As a result of the capital reorganization approved by shareholders on 12 June 2013, and the reduction of capital 
which was confirmed by the Court on 20 November 2013, the conversion terms were amended in accordance with the 
provisions of the loan stock, such that the loan stock was convertible into ordinary shares of 20p each of the company 
at a rate of 100p per ordinary share. 

On 2 June 2014 the company announced that it had reached agreement with the holders of the loan stock to extend 
the maturity date of the loan stock to 31 January 2017 coupled with an amendment of the conversion price to 76.5p per 
share, representing the closing market price of Sopheon shares immediately prior to such agreement.

Holders may convert the loan stock into Sopheon ordinary shares at any time up to the extended maturity date of  
31 January 2017, and any loan stock not converted is to be repaid at par on that date. 

2 1 .   O P E R AT I N G   L E A S E   A R R A N G E M E N T S

At the balance sheet date the group had outstanding commitments under operating leases in respect of which the total 
future minimum lease payments were due as follows:

Due within one year 
Due after one year and within five years 

Land & 
  Buildings 
2014 
$’000 

583 
1,116 
 –––––––– 
1,699 
 –––––––– 
 –––––––– 

Other 
2014 
$’000 

113 
159 
–––––––– 
272 
–––––––– 
–––––––– 

Land &
Buildings 
2013 
$’000 

537 
394 
–––––––– 
931 
–––––––– 
–––––––– 

Other
2013
$’000

99
149
––––––––
248
––––––––
––––––––

The group leases its office accommodation in the US, UK and the Netherlands and has operating leases for office 
equipment and vehicles.

Company
The company has no operating leases.

 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
4 2 

NOTES TO THE FINANCIAL STATEMENTS

4 3

2 2 .   F I N A N C I A L   I N S T R U M E N T S

Categories of Financial Assets and Liabilities

The following table sets out the categories of financial instruments held by the group.  All of the group’s financial assets 
are in the category of loans and receivables, and all of its financial liabilities are in the category of financial liabilities 
measured at amortized cost.

1. Financial Assets

Current Financial Assets
Trade receivables   
Other receivables   
Accrued income 
Cash and cash equivalents 

Non-current Financial Assets
Other receivable 

Group 

Company 

  Notes 

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000 

17 
17 
17 
18 

6,072 
9 
129 
4,735 
–––––––– 
10,945 
–––––––– 
–––––––– 

7,962 
21 
511 
4,027 
–––––––– 
12,521 
–––––––– 
–––––––– 

- 
52 
- 
789 
–––––––– 
841 
–––––––– 
–––––––– 

-
2
-
479
––––––––
481
––––––––
––––––––

16 

19 
–––––––– 
–––––––– 

19 
–––––––– 
–––––––– 

- 
–––––––– 
–––––––– 

- 
––––––––
––––––––

The group does not have any financial assets in any other categories.

2. Financial Liabilities

Current Financial Liabilities
Trade payables 
Other payables 
Accruals 
Loans and borrowings 

Non-current Financial Liabilities
Loans and borrowings 
8% convertible loan stock 2015 

Group 

Company 

  Notes 

2014 
$’000 

2013 
$’000 

2014 
$’000 

2013
$’000

19 
19 
19 
20 

20 
20 

833 
246 
1,427 
2,124 
–––––––– 
4,630 
–––––––– 

168 
3,120 
–––––––– 
3,288 
–––––––– 
7,918 
–––––––– 
–––––––– 

909 
255 
1,997 
1,513 
–––––––– 
4,674 
–––––––– 

- 
3,270 
–––––––– 
3,270 
–––––––– 
7,944 
–––––––– 
–––––––– 

74 
160 
258 
- 
–––––––– 
492 
–––––––– 

- 
3,120 
–––––––– 
3,120 
–––––––– 
3,612 
–––––––– 
–––––––– 

83
169 
376
-
––––––––
628
––––––––

-
3,270
––––––––
3,270
––––––––
3,898
––––––––
––––––––

As set out in Note 20 the carrying value of the convertible loan stock at the balance sheet date reflects a deduction for 
the reclassification of the fair value of conversion rights into equity.

 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 4 

NOTES TO THE FINANCIAL STATEMENTS

4 5

Financial Instrument Risk Exposure and Management

The group is exposed to risks that arise from its use of financial instruments.  This note describes the group’s 
objectives, policies and processes for managing those risks and the methods used to measure them. 

There have been no changes in the group’s exposure to financial instrument risks, its objectives, policies and 
processes for managing those risks or the methods used to measure them from previous periods, unless otherwise 
disclosed in this note.

Principal Financial Instruments

The principal financial instruments used by the group, from which financial instrument risk arises, are as follows:

• Trade and other receivables
• Cash and cash equivalents
• Trade and other payables
• Loan notes
• Bank line of credit
• Convertible loan stock

General Objectives, Policies and Processes

The board has overall responsibility for the determination of the group’s risk management objectives and policies and, 
while retaining ultimate responsibility for them, it has delegated the authority for designing and operating processes that 
ensure the effective implementation of the objectives and policies to the group’s finance function.  The board receives 
quarterly reports from the group finance director through which it reviews the effectiveness of the processes put in 
place and the appropriateness of the objectives and policies it sets.  The group’s risk management procedures are also 
reviewed periodically by the audit committee.

The overall objective of the board is to set policies that seek to reduce risk as far as possible without unduly affecting 
the group’s competitiveness and flexibility.  Further details regarding these policies are set out below:

a) Credit Risk

Credit risk arises principally from the group’s trade receivables, other receivables and accrued income.  It is the risk that 
the counterparty fails to discharge its obligations in respect of the instrument.

The group’s software is principally marketed at major international corporations of good credit standing, and the group’s 
historical bad debt experience is very low.  Due to the potentially large size of certain individual sales, in a particular 
year one customer can account for a substantial proportion of revenues recorded.  However, such concentrations rarely 
persist for multiple years and therefore the directors do not believe that the group is systematically exposed to credit 
risk concentration in respect of particular customers.  In 2014, the largest single customer accounted for 10 percent of 
group revenues (2013:8 percent, different customer).

Credit risk also arises from cash and cash equivalents and deposits with banks and financial institutions.  At the year 
end the group was holding a proportion of its deposits and bank balances with each of Lloyds Banking Group plc, 
Rabobank Amsterdam, and Silicon Valley Bank.

The group's customers are major international corporations of high credit standing and therefore the group does not 
typically obtain credit ratings for individual customers.  Nevertheless, current economic conditions have resulted in 
such major corporations slowing down payments and this is reflected in the ageing profile of the group’s receivables.  
However, impairment of trade receivables is very rare, and in the three years ending 31 December 2014 provisions or 
write offs against customer receivables amounted in total to less than 0.5 percent of revenues.  Such impairments do 
not arise from credit defaults, but principally from disagreements with a very small number of former customers over 
their responsibility for renewal fees for maintenance or hosting contracts.  Sopheon's policy is to pursue collection of 
such fees where invoiced, and to make provision against the applicable receivable if collection is uncertain.

 
 
4 4 

NOTES TO THE FINANCIAL STATEMENTS

4 5

The following is an analysis of the group’s trade receivables identifying the totals of trade receivables which are current 
and those which are past due but not impaired:

Total 
$’000 

Current 
$’000 

Past Due 
+30 Days 
$’000 

Past Due
+60 Days
$’000

At 31 December 2014 

At 31 December 2013 

6,072 

642 
 –––––––––  –––––––––  ––––––––– 
 –––––––––  –––––––––  ––––––––– 

5,030 

7,962 

488 
 –––––––––  –––––––––  ––––––––– 
 –––––––––  –––––––––  ––––––––– 

6,063 

400
–––––––––
–––––––––

1,411
–––––––––
–––––––––

The following is an analysis of the group’s provisions against trade receivables, analyzed between the geographical 
segments in which the group’s operations are located:

2014 

$’000 
Provision 

$’000  
  Gross 
  Value 

$’000 
Carrying 
Value 

$’000 
Gross 
Value 

2013

$’000 
Provision 

Trade receivables
   North America 
   Europe 

4,792 
1,280 
––––––––– 
6,072 
––––––––– 
––––––––– 

- 
- 
––––––––– 
- 
––––––––– 
––––––––– 

5,682 
2,280 

4,792 
1,280 

- 
- 
–––––––––  –––––––––  ––––––––– 
- 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

7,962 

6,072 

$’000
Carrying
Value

5,682 
2,280
–––––––––
7,962
–––––––––
–––––––––

The group records impairment losses on its trade receivables separately from the gross amounts receivable.  No 
impairment losses were recorded during 2014 or 2013. The main factors used in assessing the impairment of the 
group’s trade receivables are the age of the balances and the circumstances of the individual customer.

The company provides in full for amounts due from subsidiaries.  The company is exposed to credit risk in respect of 
its cash and cash equivalents, which are held in the form of current and deposit accounts with leading UK, US and 
European banking institutions.

b)  Liquidity Risk

Liquidity risk arises from the group’s management of working capital, and more particularly its ability to be consistently 
cash generative after finance charges and principal repayments on its debt instruments.  It is the risk that the group will 
encounter difficulties in meeting its financial obligations as they fall due.

The group’s policy is to maintain significant cash balances, short-term bank deposits and facilities with a view to having 
sufficient cash to meet its liabilities when they become due.  The board annually approves budgets including cash flow 
projections for each of the operating companies within the group and receives regular information as to cash balances 
held and progress against budget.  Attention is particularly drawn to the detailed discussion of the factors which enable 
the group to continue as a going concern for the foreseeable future in the section headed “Going Concern” in Note 2 to 
the financial statements.

The following table sets out an analysis of the contractual maturity of the group’s and the company’s financial liabilities 
that must be settled gross, based on exchange rates prevailing at the relevant balance sheet date.    

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 6 

NOTES TO THE FINANCIAL STATEMENTS

4 7

Group

At 31 December 2014 

Trade and other payables 
Line of credit 
Loan notes 
Future interest – loan notes 
Convertible loan stock 
Future interest – convertible loan stock 

Total financial liabilities 

At 31 December 2013 

Trade and other payables 
Line of credit 
Loan notes 
Future interest – loan notes 
Convertible loan stock 
Future interest – convertible loan stock 

Total financial liabilities 

Company

At 31 December 2014 

Trade and other payables 
Convertible loan stock 
Future interest – convertible loan stock 

Total financial liabilities 

At 31 December 2013 

Trade and other payables 
Convertible loan stock 
Future interest – convertible loan stock 

Total financial liabilities 

  On Demand
or Within 
Six Months 
$’000 

2,842 
1,979 
83 
10 
- 
125 
––––––––– 
5,039 
––––––––– 
––––––––– 

  On Demand
or Within 
Six Months 
$’000 

3,503 
1,250 
263 
7 
- 
132 
––––––––– 
5,155 
––––––––– 
––––––––– 

  On Demand
or Within 
Six Months 
$’000 

492 
- 
125 
––––––––– 
617 
––––––––– 
––––––––– 

  On Demand
or Within 
Six Months 
$’000 

628 
- 
132 
––––––––– 
760 
––––––––– 
––––––––– 

Within 
 One Year 
$’000 

Within 
Two Years 
$’000 

Within
Five Years 
$’000 

- 
- 
83 
7 
- 
125 

- 
- 
167 
7 
3,120 
250 

- 
- 
28 
- 
- 
21 
–––––––––  –––––––––  ––––––––– 
49 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

3,544 

215 

Within 
 One Year 
$’000 

Within 
Two Years 
$’000 

Within
Five Years 
$’000 

- 
- 
- 
- 
- 
132 

- 
- 
- 
- 
3,306 
23 

- 
- 
- 
- 
- 
- 
–––––––––  –––––––––  ––––––––– 
- 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

3,329 

132 

Within 
 One Year 
$’000 

Within 
Two Years 
$’000 

Within
Five Years 
$’000 

- 
- 
125 

- 
3,120 
250 

- 
- 
21 
–––––––––  –––––––––  ––––––––– 
21 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

3,370 

125 

Within 
 One Year 
$’000 

Within 
Two Years 
$’000 

Within
Five Years 
$’000 

- 
- 
132 

- 
3,306 
23 

- 
- 
- 
–––––––––  –––––––––  ––––––––– 
- 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

3,329 

132 

Total
$’000

2,842
1,979
361
24
3,120
521
–––––––––
8,847
–––––––––
–––––––––

Total
$’000

3,503
1,250
263
7
3,306
287
–––––––––
8,616
–––––––––
–––––––––

Total
$’000

492
3,120
521
–––––––––
4,133
–––––––––
–––––––––

Total
$’000

628
3,306
287
–––––––––
4,221
–––––––––
–––––––––

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 6 

NOTES TO THE FINANCIAL STATEMENTS

4 7

c) Market Risk

Market risk arises from the group’s use of interest-bearing and foreign currency financial instruments.  It is the risk that 
the future cash flows of a financial instrument will fluctuate because of changes in interest rates (interest rate risk) or 
foreign exchange rates (currency risk).  The group does not have any financial instruments that are publicly traded 
securities and is not exposed to other price risk associated with changes in the market prices of such securities.

d) Interest Rate Risk

The group’s fixed rate interest bearing liabilities consisted of the convertible loan stock with a nominal value of 
£2,000,000, which bears a fixed interest rate of 8 percent.  This liability does not give rise to interest rate risk.  The 
group also had a revolving line of credit and a term loan, on which $2,340,000 in aggregate was outstanding at 
31 December 2014, and which bore interest at a margin of 2.75 percent above the Bank’s Prime Rate, currently 
representing an effective rate of 6 percent.  Should this rate have increased 1 percent the annualized effect would have 
been to increase finance costs by $23,000. 

The group invests its surplus cash in bank deposits denominated in US Dollars, Euros or Sterling, which bear interest 
based on short-term money market rates, and in doing so exposes itself to fluctuations in money market interest rates.  
The group’s surplus cash held in the form of bank deposits at 31 December 2014 was $791,000.  During 2014 interest 
rates on money market deposits averaged at or below 0.5 percent in respect of US Dollar, Euro and Sterling deposits.  
The annualized effect of a movement of 0.5 percent in the average interest rate received on the group’s bank deposits 
at the balance sheet date would result in an increase or decrease in the group’s and the company’s interest income of 
$4,000. 

The company had no interest bearing bank deposits at the balance sheet date.

e) Currency Risk

The following is an analysis of the group’s financial assets and liabilities, analyzed by the currency in which they are 
denominated:

At 31 December 2014

Financial Assets
Receivables and accrued income 
Cash and cash equivalents 

Total financial assets 

Financial Liabilities
Trade and other payables 
Borrowings 

Total financial liabilities 

At 31 December 2013

Financial Assets
Receivables and accrued income 
Cash and cash equivalents 

Total financial assets 

Financial Liabilities
Trade and other payables 
Borrowings 

Total financial liabilities 

US Dollars 
$’000 

Sterling 
$’000 

Euro 
$’000 

Total
$’000

189 
288 

4,867 
2,424 

1,173 
2,023 
–––––––––  –––––––––  ––––––––– 
3,196 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

7,291 

477 

1,384 
2,340 

403 
3,120 

719 
- 
–––––––––  –––––––––  ––––––––– 
719 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

3,523 

3,724 

6,229
4,735
–––––––––
10,964
–––––––––
–––––––––

2,506
5,460
–––––––––
7,966
–––––––––
–––––––––

US Dollars 
$’000 

Sterling 
$’000 

Euro 
$’000 

Total
$’000

370 
149 

5,986 
1,279 

2,157 
2,599 
–––––––––  –––––––––  ––––––––– 
4,756 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

7,265 

519 

1,655 
1,513 

569 
3,306 

937 
- 
–––––––––  –––––––––  ––––––––– 
937 
–––––––––  –––––––––  ––––––––– 
–––––––––  –––––––––  ––––––––– 

3,875 

3,168 

8,513
4,027
–––––––––
12,540
–––––––––
–––––––––

3,161
4,819
–––––––––
7,980
–––––––––
–––––––––

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 8 

NOTES TO THE FINANCIAL STATEMENTS

4 9

The amount shown in respect of Sterling borrowings at 31 December 2014 represents the nominal value of the 
instrument.  As set out in Note 20 the carrying value of the instrument at the balance sheet date reflects a deduction for 
the reclassification of the fair value of conversion rights into equity.

The group’s policy is, where possible, to allow group entities to settle liabilities denominated in the functional currency 
with cash generated from their own operations in that currency.  The group also maintains cash and bank deposits 
in the currencies which are the functional currencies of its operating entities, which are the US Dollar, the Euro and 
Sterling.

The group is exposed to currency risk in respect of foreign currency denominated bank deposits and bank loans.  
Taking into account the fact that a large proportion of the group’s income and expenditure arise in US Dollars and, to a 
lesser extent, in Euros, the group’s policy is not to seek to hedge such currency risk.

Foreign currency risk also arises where individual group entities enter into transactions denominated in currencies other 
than their functional currency, with fluctuations in exchange rates giving rise to gains or losses in the income statement.  
Where the foreign currency risk to the group is significant, consideration is given to hedging the risk through the forward 
currency market and, while this would be an economic hedge of the cash-flow risk, the group does not employ hedge 
accounting.

The following table shows the effects, all other things being equal, of changes to exchange rates on the group’s profit 
after tax and on the exchange differences on retranslation of the assets and liabilities of foreign operations which is 
recognized directly in equity.  It illustrates the effects if the exchange rates for Sterling and the Euro against the US 
Dollar had been higher or lower than those which actually applied during the year and at the year end.

2014 

2013 

2014 

2013

Increase/ 
(Decrease) 
in Profit 
After Tax 
$’000 

Increase/ 
(Decrease) 
in Profit 
After Tax 
$’000 

Effect on
Exchange Differences
on Translation of
Assets and Liabilities
of Foreign Operations
$’000 

$’000 

Strengthening of Sterling in US Dollar terms by 10c  
Weakening of Sterling in US Dollar terms by 10c  
Strengthening of Euro in US Dollar terms by 10c  
Weakening of Euro in US Dollar terms by 10c  

(58)   
55   
31    
(35)  

(26)  
30  
89  
(86)  

(115)  
122  
77  
(63)  

  ––––––––– 
  ––––––––– 

–––––––––  ––––––––– 
–––––––––  ––––––––– 

(488)
488
121 
(120)
–––––––––
–––––––––

The company holds certain assets, mainly bank deposits, and liabilities denominated in the functional currencies of its 
principal operating subsidiaries, which are the US Dollar, the Euro and Sterling.  The following table shows the effects, 
all other things being equal, of changes to exchange rates at the year end on the profit after tax of the company.  It is 
based on the company’s assets and liabilities at the relevant balance sheet date.

2013

2014 
Increase/(Decrease)  
in Profit After Tax 
$’000

$’000 

Strengthening of Sterling in US Dollar terms by 10c            
Weakening of Sterling in US Dollar terms by 10c                   
Strengthening of Euro in US Dollar terms by 10c  
Weakening of Euro in US Dollar terms by 10c                        

(187)             (220)
190                220  

48  
(48)                 (8) 
–––––––––  ––––––––– 
–––––––––  ––––––––– 

8

f) Capital

The group considers its capital to comprise its share capital and its special reserve and equity reserve less the 
accumulated retained losses.  The group is not subject to any externally imposed capital requirements.  In managing its 
capital, the group’s primary objective is to support the development of the group’s activities through to the point where 
they are cash generative on a sustained basis.

The group’s share capital is all equity capital and is summarized in Note 23.  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 8 

NOTES TO THE FINANCIAL STATEMENTS

4 9

2 3 .   S H A R E   C A P I TA L

Issued and Fully Paid 

Ordinary shares of 20 pence each 

2014 
  Number 

2014 
$’000 

2013 
Number 

2013
$’000

 7,279,000 
7,279,000 
 –––––––––  –––––––––  ––––––––– 
 –––––––––  –––––––––  ––––––––– 

2,354 

2,354
–––––––––
–––––––––

On 12 June 2013 shareholders approved a capital reorganization and reduction of capital, details of which are set out in the 
Directors’ Report. 

Throughout the year the company has had in issue one class of ordinary shares, which have at no time carried any right to 
fixed income.  As referred to in the Directors’ Report, on 10 October 2014 shareholders approved a share consolidation, on 
the basis of one new ordinary share of £100 nominal value for every 500 ordinary shares of 20p each.  On 18 December 
2014 shareholders approved a share subdivision, whereby each ordinary share of £100 nominal value was subdivided into 
500 ordinary shares of 20 pence each, thereby reversing the share consolidation. 

At 31 December 2014 the company had outstanding 25,138 warrants to subscribe for ordinary shares of 20p each at a 
price of 400p per share, which were issued in June 2007 to BlueCrest Capital Finance LLC in connection with the financing 
of the acquisition of Alignent Software, Inc.  The warrants have a 10 year life.   

2 4 .   C A P I TA L   R E S E R V E S

Group  

At 1 January 2013   
Recognition of share-based payments  
Lapsing or expiry of share options  
Reduction of capital   
Expenses of capital reorganization  

At 1 January 2014   
Recognition of share-based payments  
Lapsing or expiry of share options  

At 31 December 2014  

Company  

At 1 January 2013  
Recognition of share-based payments  
Lapsing or expiry of share options  
Reduction of capital   
Expenses of capital reorganization  

At 1 January 2014   
Recognition of share-based payments  
Lapsing or expiry of share options  

At 31 December 2014   

Capital 
Share  Redemption 
Reserve 
$’000 

  Premium 
$’000 

Equity 
Reserve 
$’000 

Special
Reserve 
$’000 

  84,230 
- 
- 

(84,230)  

- 
 –––––––– 
- 
- 
- 
 –––––––– 
-  
 –––––––– 
 –––––––– 

4,663 
- 
- 

(4,663)  
-  
–––––––– 
- 
- 
- 
–––––––– 
-  
–––––––– 
–––––––– 

1,033 
121 
(729) 
-  
-  
–––––––– 
425 
158 
(2) 
–––––––– 
581 
–––––––– 
–––––––– 

- 
- 
- 
5,104  
(31) 
–––––––– 
5,073 
- 
- 
–––––––– 
5,073 
–––––––– 
–––––––– 

Capital 
Share  Redemption 
Reserve 
$’000 

  Premium 
$’000 

  84,230 
- 
- 
(84,230) 
-  
 –––––––– 
- 
- 
- 
 –––––––– 
- 
 –––––––– 
 –––––––– 

4,663 
- 
- 
(4,663) 
-  
–––––––– 
- 
- 
- 
–––––––– 
- 
–––––––– 
–––––––– 

Equity 
Reserve 
$’000 

Special
Reserve 
$’000 

1,033 
121 
(729) 
- 
-  
–––––––– 
425 
158 
(2) 
–––––––– 
581 
–––––––– 
–––––––– 

- 
- 
- 
5,104 
(31) 
–––––––– 
5,073 
- 
- 
–––––––– 
5,073 
–––––––– 
–––––––– 

Total
$’000

89,926
121
(729)
(83,789)
(31)
––––––––
5,498
158
(2)
––––––––
5,654
––––––––
––––––––

Total
$’000

89,926
121
(729)
(83,789)
(31)
––––––––
5,498
158

(2) 
–––––––– 
5,654
––––––––
––––––––

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 0 

NOTES TO THE FINANCIAL STATEMENTS

5 1

Share premium represents the premium arising on the issue of shares and its use is governed by the provisions of the 
Companies Act 2006. 

The capital redemption reserve is a non-distributable reserve arising from the cancellation in 2001 of deferred shares. 

The equity reserve comprises the fair value of share-based payments to employees pursuant to the group’s share 
option schemes, the fair value of warrants to subscribe for Sopheon shares issued to BlueCrest Capital Finance LLC, 
and the equity component of the group’s 8 percent convertible loan stock 2017. 

In addition, investment by the group’s employee share ownership trust (the “Esot”) in the company’s shares is deducted 
from equity in the consolidated balance sheet as if they were treasury shares, by way of deduction from the equity 
reserve.  At 31 December 2014 and at 31 December 2013, the Esot held 7,000 ordinary shares of 20p each in the 
company, which represents 0.1 percent of the company’s ordinary share capital.  The equity reserve includes a 
deduction of $17,000 (2013: $17,000) which represents the cost of the shares held by the Esot at 31 December 2014. 

The purpose of the Esot is to facilitate the company’s policy of offering participation in the ownership of its shares 
to employees for reward and incentive purposes.  At 31 December 2014 and at 31 December 2013, no shares held 
by the Esot were under option or had been gifted to any employees.  Arrangements for the distribution of benefits to 
employees will be made at the Esot’s discretion in such manner as the Esot considers appropriate.  Administration 
costs of the Esot are accounted for in the profit and loss account of the company as they are incurred.

On 20 November 2013 the Court confirmed the cancellation of the whole of the company’s share premium and capital 
redemption reserves, as part of the capital reorganization approved by shareholders of the company on 12 June 2013.

The special reserve represents the net reserve arising from the cancellation the company’s 7,279,000 deferred 
shares of 80p each referred to in Note 23, amounting to $9,415,000, the cancellation of share premium amounting to 
$84,230,000 and of the capital redemption reserve amounting to $4,663,000, and after offsetting $93,204,000 against 
accumulated losses. The special reserve is a non-distributable reserve which may be used, amongst other purposes as 
approved by the court, for the same purposes as if it were a share premium reserve.

2 5 .   R E T I R E M E N T   B E N E F I T   P L A N S

The group operates defined contribution retirement benefit plans which employees are entitled to join.  The total 
expense recognized in the income statement of $234,000 (2013: $243,000) represents contributions paid to such plans 
at rates specified in the rules of the plans.

2 6 .   R E L AT E D   PA R T Y   T R A N S A C T I O N S

Details of transactions between the group and related parties are disclosed below.

Compensation of Key Management Personnel

Details of directors’ remuneration are given in Note 7.  The total remuneration of executive directors and members of 
the group’s operating and executive management committees during the year was as follows:

Emoluments and benefits 
Pension contributions 
Share-based payments 

2014 
$’000 

2013
$’000

1,898 
47 
119 
––––––– 
2,064 
––––––– 
––––––– 

2,097 
55
93
–––––––
2,245
–––––––
–––––––

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 0 

NOTES TO THE FINANCIAL STATEMENTS

5 1

Transactions with Related Parties who are Subsidiaries of the Company

The following is a summary of the transactions of the company with its subsidiaries during the year:

Net amounts borrowed/(repaid) by subsidiaries by way of interest-free loans 
Net management charges to subsidiaries 

2014 
$’000 

2013
$’000

(1,025) 
448 
––––––– 

1,356
482
–––––––

The amounts owed by subsidiary companies to the parent company at 31 December 2014 totaled $62,870,000  
(2013: $67,565,000).  A full provision has been made against these amounts, which are unsecured and are subordinated 
to the claims of all other creditors.

During 2014 and 2013 the company granted share options to employees of subsidiary companies.  Details of grants of 
share options are disclosed in Note 27.

Other Related Party Transactions

There were no other related party transactions during the year under review or the previous year.

2 7 .   S H A R E - B A S E D   PAY M E N T S

Equity-settled Share Option Schemes

The group has a number of share option schemes for all employees.  Options are exercisable at a price equal to the 
market price on the date of grant.  The normal vesting periods are as set out below.

Vesting 

Sopheon plc (USA) stock option plan 
Sopheon UK approved share option scheme 
Sopheon UK unapproved share option scheme 
Sopheon NV share option scheme 

In three equal tranches between the first and third anniversary of grant
On third anniversary of grant
Immediate or as per USA plan
Immediate or as per USA plan 

Following the capital reorganization which became effective on 12 June 2013, the terms of all share options outstanding 
on that date were amended in accordance with the terms of the respective schemes.

 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
NOTES TO THE FINANCIAL STATEMENTS

Details of the share options outstanding during the 2013 and 2014 are as follows:

Outstanding at 1 January 2013 
Options granted in 2013 prior to capital reorganization 
Options lapsed in 2013 prior to capital reorganization  

Share options outstanding immediately prior to capital 
   reorganization becoming effective 

Share options outstanding immediately following the capital
   reorganization becoming effective 
Share options granted in 2013 subsequent to capital reorganization   
Options lapsed or cancelled in 2013 subsequent to capital reorganization 

Outstanding at 31 December 2013 
Options granted in 2014 
Options lapsed in 2014 

Outstanding at 31 December 2014 

Exercisable at 31 December 2014          

Exercisable at 31 December 2013 

  Number of 
Share 
 Options 

Weighted
Average
Exercise
Price
£

  12,179,680 
    1,117,500 

(1,128,300)   

0.10
0.05
0.11    

  ––––––––– 

–––––––––

  12,168,880 
  ––––––––– 

0.11
–––––––––

608,440 
233,704 
(231,204) 
  ––––––––– 
     610,940 
       38,500 
      (13,500) 
  ––––––––– 
     635,940 
  ––––––––– 
  ––––––––– 
335,492 
  ––––––––– 
  ––––––––– 
 157,095 
  ––––––––– 
  ––––––––– 

2.11
0.85
3.65
–––––––––
1.04
0.55
0.96
–––––––––
1.01
–––––––––
–––––––––
1.12
–––––––––
–––––––––
1.27
–––––––––
–––––––––

No share options were exercised during the year (2013: Nil).  The options outstanding at the end of the year have a 
weighted average contractual life of 8.1 years (2013: 9.0 years).

During the year share options were granted on 19 September 2014, when the exercise price of options granted was 
55p and the estimated fair value was 32.6p.

During 2013 share options were granted on 18 April 2013 (prior to the capital reorganization referred to in Note 23), 
when the exercise price of options granted was 5.25p and the estimated fair value was 3.11p and on 5 December 2013 
(after the capital reorganization) when the exercise price of options granted was 85p and the estimated fair value was 
50.33p. 

The fair values for options granted are calculated using the binomial option-pricing model.  The principal assumptions 
used were:

Date of Grant 

Share price at time of grant  
Exercise price  
Expected volatility    
Risk-free rate  
Expected dividend yield  

  September 
2014 

December 
2013 

April
    2013

55p  
55p  
40%  
5%  
Nil   

85p  
85p  
40%  
5%  
Nil  

5.25p  
5.25p  
40% 
5% 
Nil

The expected contractual life of the options used was ten years.  Expected volatility was determined by reference to the 
historic volatility of the company’s share price in the period before the date of grant.

 52 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D I R E C T O R S

Barry Mence, Chairman.  Barry Mence has served as executive chairman and as a director and substantial 
shareholder of Sopheon since its inception in 1993 when he was one of the founding members.  From 
1976 to 1990, Barry was the major shareholder and group managing director of the Rendeck Group of 
Companies, a software and services group based in the Netherlands. 

Andrew Michuda, Chief Executive Officer.  Andrew (Andy) Michuda was appointed chief executive officer 
of Sopheon in 2000.  From 1997 to 2000, he served as chief executive officer and an executive director of 
Teltech Resource Network Corporation, which was acquired by Sopheon.  Prior to joining Sopheon, Andy 
held senior leadership positions at Control Data.

Arif Karimjee,  ACA, Chief Financial Officer.  Arif Karimjee joined Sopheon as chief financial officer in 2000.  
Arif served as an auditor and consultant with Ernst & Young in the United Kingdom and Belgium from 1988 
until joining Sopheon.

Stuart Silcock,  FCA, Non-Executive Director.  Stuart Silcock has served as a director of Sopheon since 
its inception in 1993 when he was one of the founding members of the company.  Since 1982 Stuart has 
been a principal Partner in Lawford & Co chartered accountants.  Stuart was a non-executive director of 
Brown and Jackson plc for four years from 2001 and has held a number of other directorships in the United 
Kingdom.

Bernard Al,  Non-Executive Director.  Bernard Al was appointed as director of Sopheon in 2001.  He is a 
former chief executive officer of Wolters Kluwer in the Netherlands and has a background in linguistics.  
Bernard is also the non-executive chairman of CB-Logistics in the Netherlands and he has held a number 
of other non-executive positions in international companies during the last ten years.

Daniel Metzger,  Non-Executive Director.  Dan Metzger was until 1998 Lawson Software’s EVP Marketing, 
where he helped the company grow its revenues from $13m to $400m.  Since then he has held similar 
roles at Parametric Technologies, and also at auxilium and nQuire, subsequently sold to Parametric and 
Siebel respectively.  As a strategy consultant, Dan has helped numerous technology companies reach and 
exceed their growth objectives. Dan is currently CEO of Oppsource Inc.

 52 53